No retraction, correction or concern found when last checked on Oct 15, 2026.

Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain

Magdalena Miranda, Juan Facundo Morici, María Belén Zanoni and 1 more (opens in a new tab)

Frontiers in Cellular Neuroscience · 2019 · Review · CC BY

doi:10.3389/fncel.2019.00363 (opens in a new tab)

Abstract

Brain Derived Neurotrophic Factor (BDNF) is a key molecule involved in plastic changes related to learning and memory. The expression of BDNF is highly regulated, and can lead to great variability in BDNF levels in healthy subjects. Changes in BDNF expression are associated with both normal and pathological aging and also psychiatric disease, in particular in structures important for memory processes such as the hippocampus and parahippocampal areas. Some interventions like exercise or antidepressant administration enhance the expression of BDNF in normal and pathological conditions. In this review, we will describe studies from rodents and humans to bring together research on how BDNF expression is regulated, how this expression changes in the pathological brain and also exciting work on how interventions known to enhance this neurotrophin could have clinical relevance. We propose that, although BDNF may not be a valid biomarker for neurodegenerative/neuropsychiatric diseases because of its disregulation common to many pathological conditions, it could be thought of as a marker that specifically relates to the occurrence and/or progression of the mnemonic symptoms that are common to many pathological conditions.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 15, 2026. Paragraph numbers are ours, so an answer can point at one.

BDNF: A Dynamically Regulated Player in Synaptic Plasticity and Memory

1The brain derived neurotrophic factor (BDNF) belongs to a family of neurotrophins that have a crucial role in survival and differentiation of neuronal populations during development. In the adult brain, BDNF also maintains high expression levels and regulates both excitatory and inhibitory synaptic transmission and activity-dependent plasticity.

2The expression of BDNF is regulated during transcription and translation, and also by post-translational modifications. The presence of a complex multi-level regulation demonstrates the importance and diversity of BDNF functions. Transcription is controlled by multiple promoters that determine activity-dependent and tissue specific expression. There have been identified at least four BDNF promoters in the rat, each one driving the transcription of mRNAs that contain one of the 8 non-coding exons spliced to the common 30 coding exons, which produce an heterogeneous population of BDNF transcripts. BDNF splicing has been described for several species, including humans, mice, and rats. Additionally, the expression of specific BDNF exons can be regulated by epigenetic mechanisms, suggesting that environmental experiences dynamically influence mature BDNF levels.

3Regarding the pattern of expression of BDNF in the brain, high levels of this molecule have been detected in the hippocampus, amygdala, cerebellum and cerebral cortex in both rodents and humans, with the highest levels found in hippocampal neurons. Lower levels of BDNF have been detected in organs such as the liver, heart, lung, among others. The regulation of each transcript is controlled and/or modulated by factors like neuronal activity, exercise, antidepressants, stress, and hormones such as estrogens.

4Brain derived neurotrophic factor is synthesized as the precursor proBDNF, that can be stored in either dendrites or axons, and undergoes cleavage intra or extracellularly to produce a mature BDNF protein. BDNF is released in an activity dependent manner as a mixture of pro and mature BDNF. Interestingly, BDNF and proBDNF are associated with opposing effects on cellular function, which gives BDNF protein function an additional level of complexity. The proBDNF form is secreted under both pathological and non-pathological conditions. ProBDNF preferentially binds p75 NTR receptor, which facilitates LTD and induces apoptosis. On the other hand, BDNF in its mature form binds specifically to tyrosine kinase receptors (TrkB) and promotes cell survival, facilitates LTP and increases spine complexity. When p75NTR is co-expressed with TrkB receptor it increases neurotrophins binding affinity thereby facilitating ligand discrimination. In this way, proBDNF can be thought as part of a regulatory mechanism of BDNF activity in non-pathological conditions. In addition, the truncated forms of TrkB receptor can act as dominant negative inhibitors of BDNF signaling by internalizing and clearing BDNF from the synapse (; Figure 1).

5Many studies have shown the critical role of BDNF for the regulation of plastic changes in the adult brain, including regulation of the trafficking, phosphorylation and expression levels of NMDARs associated with augmented synaptic strength. Due to its critical role in LTP, BDNF has been postulated to be an essential part of the cellular mechanism supporting memory formation and maintenance by promoting synaptic consolidation. According to this hypothesis, BDNF increases memory storage by favoring changes in spine morphology leading to the stabilization of LTP. BDNF can also increase the number, size and complexity of dendritic spines, probably through unpregulated actin polymerization. Furthermore, BDNF increases neurogenesis through changes in cell survival and proliferation.

6Changes in synaptic connections are thought to support memory storage. There are several lines of evidence that directly link BDNF with learning and memory. For example, BDNF could be a mediator of the plastic changes underlying both spatial and recognition memory processes.

7In this review, we will focus on the role of BDNF in cognitive function in the adult brain under normal and pathological conditions, and evaluate the potential therapeutic actions of BDNF for the treatment of cognitive alterations associated with aging, neuropsychiatric and neurodegenerative diseases. We will particularly focus on the effects of these treatments on mnemonic function.

The BDNF Val66Met Polymorphism

8In the human BDNF gene, a common single nucleotide polymorphism identified with a Met to Val substitution at codon 66 in the pro-domain of BDNF, called rs6265 or Val66Met polymorphism, affects synaptic targeting of BDNF-containing vesicles and activity-dependent neuronal release of BDNF. Met66 homozygous knock-in mice showed a selective impairment in activity-dependent synaptic plasticity in vitro. Additionally, exogenous application of proBDNF in Val-carriers facilitated LTD and inhibited LTP, while not in Met carriers. Because of its frequency in the human population [up to 30% Met carriers in a European sample] and its association with lower serum levels of BDNF, this single nucleotide polymorphism has been a matter of great interest. This polymorphism has been associated with structural and functional differences in the brain, such as synaptic plasticity and memory performance. Some of these structural changes include volumetric decreases in specific regions -such as the hippocampus, the parahippocampal gyrus, the prefrontal cortex and the amygdala-. The presence of the Met allele is, in turn, associated with poor mnemonic performance on verbal tasks both at short and long delays and also deficits in working and spatial memory tasks. Since most studies relayed mainly on tasks that evaluate item memory, and particularly, verbal memory, the effects over other more complex cognitive functions remain to be tested. did evaluate multiple types of memories, finding only an influence on visuospatial memory, although describes an additional effect of associative memory.

9Besides these correlational studies of Met allele dosage, hippocampal volume/activation and memory performance in healthy subjects, evidence for a role of Val66Met polymorphism in brain structure and function is not conclusive and, even meta-analysis studies show patterns of conflicting results. conducted three separate meta-analyses to determine the effect of the Val66Met polymorphism on declarative memory performance, hippocampal volume and hippocampal activation in humans. They reported that all these measures are reduced in carriers of the Met allele compared to Val homozygotes and this effect cannot be explained by random variables such as age, gender or diagnosis criteria. However, argued that the effect sizes of fMRI data are susceptible to the method used to select the voxels and that the one used in Kambeitz et al. may have led to an inflated estimate of the effect size. In fact, the meta-analysis conducted by did not detect a significant association between the BDNF Val66Met polymorphism and several phenotypes including general cognitive ability, memory, executive function, visual processing skills, and cognitive fluency. They hypothesized alternative scenarios to explain this incongruence in the literature and proposed that instead of being grouped by their behavioral similarity, cognitive phenotypes should be categorized depending on the brain activation pathways engaged. Although an important group of studies could not found an association between Val66Met genotype and memory performance, the results linking BDNF polymorphism and memory are not likely spurious. It is possible that differences in the effect that the BDNF gene exerts across the lifespan and the uncontrolled effects of variables such as gender, stress and physical exercise, known to affect BDNF levels, may have led to a dilution of the effect in certain samples. Furthermore, Met carriers might be able to compensate for the deficiency in BDNF levels. In fact fMRI studies suggest that they present increased medial temporal lobe activity during the engagement of an episodic memory task when compared with non-carriers, and this might “hide” the potential deficits. In conclusion, these studies suggest that presence of the Met allele may confer a disadvantage in cognitive performance, and particularly episodic memory (for a review, see ), but that the effects of BDNF polymorphism may be too complex to be analyzed under the idea of a simple “risk allele.”

BDNF in the Aging Brain

10Aging is a major risk for the development of cognitive disorders. Cognitive performance gradually declines with age, probably as a result of cellular and metabolic changes that lead to a progressive reduction in synaptic plasticity in brain regions crucial for cognitive functions. Aging is related to a significant shrinkage of gray matter, an important reduction in the number of synapses and also changes in neuroplasticity-related proteins. The hippocampus is a brain region with high levels of plasticity-related molecules and is particularly sensitive to aging-related cellular alterations that lead to volume reductions. Particularly numerous changes were reported in the dentate gyrus local inhibitory and excitatory circuitry. Furthermore, decreases in adult neurogenesis in the dentate gyrus start emerging at middle age and continue throughout the aging process. Other structures also linked to episodic memory formation, such as the frontal and entorhinal cortices, also show volume reduction and may contribute to the deterioration of cognitive function.

11At the cellular level, changes in hippocampal LTP have also been reported in aged animals, with deficits either related to induction, maintenance and/or expression of LTP depending on the stimulation pattern used for induction. Given that alterations in the thresholds for LTP and LTD in the MTL region have been associated with impairments in long-term memories (for review, see ), age-related cognitive impairment could also be linked to altered LTP function.

12In fact, one of the most consistent plasticity-related deficits associated with aging is the reduction in neurotrophic signaling. BDNF-LTP in the dentate gyrus is impaired in the aged brain, and may be reverted by endogenous BDNF induction by manipulations such as ampakine administration, which can also ameliorate age-associated memory deficits in rodents. Since dysfunction of synaptic plasticity and changes in neuronal activity are associated with worse performance in different cognitive tasks, efforts have been done to link changes in BDNF levels to aging-dependent cognitive decline and to the related alterations in structural and functional integrity of neuronal networks (for review, see ). suggested that age-dependent impairment in cognitive function could be associated with decreases in BDNF expression in the primary regions of the brain affected by aging. Consistent with this idea, the circulating concentrations of BDNF are reduced in aged primates and humans and brain concentration reduced in rats. In aged rodents, the BDNF system is affected at different levels, including reduced transcription, protein synthesis and processing, however, other publications could not find an association between age-related plastic changes and BDNF. The found reductions correlate with hippocampal shrinkage, spatial memory decline and neuronal atrophy. For example, higher BDNF mRNA induction levels were reported after Water Maze task on unimpaired rats in comparison with aged animals. The decrease in BDNF levels observed in aged individuals, was accompanied by a reduction in the expression and/or activation of TrkB receptor and a concomitant increase in the levels of proBDNF and p75NTR, suggesting the presence of additional age-related deficits in BDNF signaling pathway and in the processing of proBDNF to mature BDNF. Additionally, these changes were negatively correlated with performance on the Water Radial Maze. Furthermore, the induction of specific BDNF transcripts after fear conditioning is altered in aged rats, suggesting that aging is not only associated with reduced neurotrophin expression under resting conditions, but might lead to a functional impairment of BDNF in response to a specific task. This is consistent with the aforementioned role of BDNF in activity and experience-dependent structural and functional connectivity changes.

13However, some researchers found no change or even an increase in BDNF associated with aging. This could suggest that the loss of hippocampal BDNF is not part of the mechanisms involved in age-related cognitive decline. However, considering that neuronal cell death is an undoubtedly important element of age-related cognitive impairment, a transient BDNF-related response to neuronal degeneration could be the underlying reason for the increasing levels of hippocampal BDNF reported in some studies. However, since in vivo measurements of BDNF in the brain are not possible, studies in humans rely on inferences about the levels of BDNF on central nervous system. Given that there is evidence that BDNF can cross the blood-brain barrier, these studies assume that serum BDNF is a proxy of BDNF levels in the brain. Consistently, measures of BDNF in the central nervous system (brain BDNF, b-BDNF) correlate with measures of BDNF from the periphery (serum BDNF, sBDNF) with as much as 75% of brain origin BDNF. However, the functional significance of BDNF in the serum is a matter of debate. BDNF is also secreted in several peripheral sites such as platelets, lymphocytes, and skeletal and smooth muscle cells, and also recent studies have questioned the idea of BDNF being able to cross the blood-brain barrier. Another important consideration in these measurements is whether pro and mature forms of BDNF are being measured, because only some assays can differentiate mature BDNF and, considering that they can have opposing effects, these should be taken into account. For this reason, the results of serum studies should be interpreted cautiously, as this could be a potential cause for inconsistencies reported in sBDNF levels between studies. The use of enriched extracellular vesicles of neuronal origin from peripheral blood could provide a novel way to bypass these issues since they could more closely reflect brain changes compared to plasma.

14There are several reasons to think that a decrease in BDNF levels could be detrimental to normal brain functioning, like its role in synaptic plasticity, as described above. Another motive is that BDNF exerts various trophic effects on hippocampal neurons that could help counteract the noxious effects of neuronal cell death. In fact, high levels of BDNF in the hippocampus are related to both survival and differentiation of dentate gyrus progenitor cells in the adult, and low levels of BDNF have been linked to deficient neurogenesis in aged animals. Moreover, BDNF is known to increase with oxidative stress as part of an antioxidant defense during aging. Neuronal loss is an important component of normal aging, however, it does not contribute significantly to learning and memory impairments, suggesting that memory deficits associated with aging are more likely related to alterations in synaptic physiology and aberrant cell signaling, that might contribute to an altered connectivity.

15While aging-related neuroanatomical changes are evident, there is an enormous variability amongst healthy individuals in the pattern of cognitive decline. Memory performance is also partly under genetic control, probably because of age-sensitivity in many cognitive processes. Genetic variance could explain these individual differences in cognitive capacity, especially since heritability of cognitive function increases over the lifespan as brain resources decrease, and can account for as much as one third of the variance in cognitive decline. Both apolipoprotein E (APOE) and BDNF have been associated with variance in cognitive performance in healthy individuals more frequently than other genes, although some results have not been reliably replicated.

16Since BDNF decreases throughout life, it would be interesting to assess the possible associations between the Val/Met polymorphism and age-related cognitive decline. For example, reported poor verbal recall in a sample of healthy elderly Met homozygotes, and found that Met carriers showed greater age-related decline in hippocampal activation during both encoding and retrieval, while other studies also limited to older adults found no impact of age on cognitive tests evaluating learning and memory. Considering these results, this polymorphism could help understand individual differences in cognitive function by genetic-dependent changes in neurotransmitter and neurotrophic factor levels, amongst other factors. However, since reports indicate that both APOE and BDNF polymorphisms accounts for less than 2.3% of the variance, it is fundamental to take into account the complex interplay between associations with other genes and interactions with environmental factors to interpret these results. Many environmental and hormonal factors such as physical exercise, caloric restriction, estrogen levels, and environmental enrichment can influence BDNF levels, making it challenging to link BDNF to age-related memory impairment and hippocampal atrophy. For example, BDNF genotype can modulate the effect of physical exercise on episodic memory performance and brain volume. This is evident by the fact that only Val homozygous benefited from physical exercise with larger MTL volume and hippocampal gray matter, whereas in Met carriers the contrary effect was found. In another study, in a cohort aged 65 or older the strength of the association between incidence of cognitive decline and physical activity increased with the number of Met alleles, suggesting that the Met allele may confer vulnerability to dementia in elders with less physical activity. On the other hand, there are studies reporting a reduced vulnerability of Met carriers to age-related decline in executive function, pointing toward a differential effect of BDNF on cognitive function related to the areas supporting the task.

17The influence of BDNF on cognitive function may change across the lifespan. In fact, the effects of the BDNF Val66Met polymorphism on brain structure and cognitive function were found to differ in an age-dependent manner: while Met carriers showed a reduction in episodic memory performance and hippocampal/parahippocampal volume in samples of around 65 years in comparison to Val carriers, in the elderly (mainly samples of around 75 years) Val/Val individuals had diminished entorhinal cortex thickness, white matter tract integrity, and episodic memory performance. It has been hypothesized that this effect could be related to changes in the level of cleavage, since cleavage molecules such as tPA are known to decline with age which could create a paradoxical effect where greater BDNF secretion would, in fact, lead to cognitive decline. Another explanation could be a decrease in the penetrance of the BDNF genotype across the lifespan, as other factors such as the independent incidence of age-related diseases increase their influence on brain structure and cognition. In fact, there are results that suggest that Met carriers have more preserved frontostratial functions than Val/Val subjects, what may lead to an increase in the use of stratium-dependent mnemonic strategies, that could give a potential advantage on Met carriers that might hinder the original deficits reported in young individuals. This might help explain conflicting results in this regard, since there are studies showing that aged Met-carriers still have deficits in mnemonic performance and they experience a steeper impairment in memory tasks as they age and have diminished performance in remembering neutral faces when compared with Val/Val individuals.

18Aging is normally accompanied by a loss of memory function. Episodic memories are particularly more sensitive to the aging process than procedural or non-declarative memories. Within the limits of the episodic memory domain, some aspects can be more vulnerable to aging than others. For example, associative memory tasks that require binding of multiple pieces of information can be more sensitive to the aging process. This deficit is mostly related to spatial and recognition memory loss. The vulnerability of particular mnemonic processes to aging is probably due each of these functions being supported by distinct brain regions showing differential rates of functional decline with age. Diminished input from the EC to the DG could contribute to deprive the HP from sensory information crucial for discrimination of novel versus familiar stimuli when this stimuli are similar, and in fact reductions in DG-CA3 connectivity are associated with spatial learning decline in old animals. The medial temporal lobe region (MTL), that is thought to support episodic memory function, is particularly vulnerable to cellular alterations that happen during aging and/or pathological dysfunction. Since episodic memory decline is correlated to decreases in hippocampal volume, these changes could explain age related mnemonic deficits. Another important structure for episodic memory in the MTL is the perirhinal cortex (Prh), a region involved in the discrimination of novel and familiar stimuli that is particularly crucial to solve tasks involving ambiguous features. Aging alters discrimination in both in rats and humans increasing a propensity to identify novel stimuli as familiar. This effect was, in some cases, interpreted as a deficit in the ability to bind features of an object, so that decisions are made based on the familiarity of a single component. The consequence is the incapacity to detect novel compositions of familiar features. In fact, complexity and ambiguity of the features was proposed as a determining variable in recognition memory deficits in aged rats, as well as in Prh-lesioned animals using a configural task with complex objects. Several molecular and biochemical alterations have been reported in the Prh of aged animals that could contribute to the associated cognitive deficits. Since exposure to novel objects is related to an increase in BDNF levels in the Prh, and familiarity discrimination in the presence of ambiguous stimuli (and not clearly distinguishable ones) is impaired with BDNF antisense ODNs infusions during a restricted time window after the task, BDNF is an interesting molecular candidate that could help to establish a link between molecular and biochemical alterations and the pattern of both spatial and recognition memory deficits associated with aging. In particular, because optimal cognitive function is linked to efficient neuronal plasticity, these memory deficits might be coupled to alterations in the expression and regulation of plasticity-related proteins such as BDNF, a protein whose expression is both affected in the aging brain and is crucial for memory consolidation and particularly for discrimination of similar memories.

19In correspondence with this idea, decrease in BDNF expression has been associated with neuronal atrophy and death occurring in some neurological disorders. Administration of exogenous BDNF can prevent pathological changes in the nervous system associated with aging [but see for inconsistent results; for review, ], and can rescue both BDNF-induced LTP and spatial memory performance in aged animals. Since BDNF has been linked to synaptic plasticity, neurogenesis, neuronal survival and protection against brain insults, the above results imply the possibility that BDNF could act as a synaptic repair molecule. There are a few evidence that support this idea, for example, acute application of the TrkB agonist 7,8-dihydroxyflavone rescues synaptic plasticity in the hippocampus of aged rats in vitro. Additionally, chronic treatment also prevents age-related impairments in contextual and cued fear conditioning with a simultaneous normalization of the spine levels that normally decrease with age. Furthermore, the Lou/C rat, an animal model of successful aging that presents a preserved cognitive performance across its longer lifespan, showed higher hippocampal BDNF than Wistar rats and a decrease in proBDNF with age. This contrasts with the increase in proBDNF seen in aged Wistar rats. However, the beneficial effect of BDNF on neuroprotection and mnemonic performance in rats decrease as age increases, probably due to additional changes in the processing and signaling pathway. Consistent with the role of BDNF on synaptic plasticity and memory, elderly Lou/C rats never showed short- or long-term memory decline in recognition memory tasks or impaired LTP. However, found that learning-associated cognitive training could increase TrkB receptor expression in aged animals and also increased proBDNF processing both in aged and young rats, indicating that learning leads to a strengthening of BDNF pathway, especially in aged animals where this pathway is affected.

BDNF and Alzheimer’s Disease

20Reduced levels of BDNF have been reported not only under normal aging conditions but also in pathological conditions including Huntington (HT), Alzheimer’s disease (AD), and Parkinson’s disease. However, the profile of cognitive deficits greatly differs between these pathologies according to the brain regions affected by degeneration. For example, the most profound BDNF deficits are reported in the hippocampus, parietal, entorhinal and frontal cortex for AD and in the striatum and motor cortex for HT. In this section we will focus on AD because it starts mainly as impairment in declarative memories, without affecting other neurological functions. It has been proposed that this feature is related to the degenerative profile of the disease that starts in the hippocampus, parahipocampal cortices and amygdala, but not in primary sensory and motor cortices.

21There is a substantial amount of studies supporting the idea that neurotrophic factors are crucial for the etiology of AD, in particular BDNF. BDNF protein and mRNA levels as well as proBDNF are reduced in the post-mortem brain of AD patients compared with age-matched controls, with no changes in TrkB levels. This reduction was also reported in Mild Cognitive Impairment (MCI), a potentially prodromal stage of AD. Furthermore, reduced circulating levels of BDNF were also found in MCI. BDNF levels are correlated to the severity of the disease and with episodic memory performance in patients, suggesting that these decreases could be related to the pathogenesis of the disease. In conclusion, downregulation of BDNF and proBDNF are thought to be an underlying mechanism related to early AD. However, found that patients in the early stages of AD had significantly higher sBDNF levels than patients in the late stages and also than age-matched controls. This highlights that it is difficult to establish a causal link between BNDF downregulation and the development of this neurodegenerative disease because the pathology is accompanied by a loss of cell density and dendritic spines that could secondarily affect BDNF levels. In this regard, there are also post-mortem and serum level studies that report an increase in BDNF and TrkB concentrations in the hippocampus and parietal cortex of AD patients. This increase may be related to compensatory mechanisms that could contribute to the repair by degradation of β-amyloid. In addition, other potential moderators could contribute to differences and heterogeneity seen in these studies. Differences in diagnostic criteria, stages of the disease, sex and education and the use of pharmacological treatments such as acetylcholinesterase inhibitors or psychotropic medication that are known to raise BDNF levels, or could come from other potential sources outside the CNS such as immune cells.

22Given that synaptic loss is the major correlate of cognitive impairment, much stronger than the presence of plaques or tangles, there is a recent view of AD as a “synaptic pathology”. Aβ monomers are normally generated and secreted at firing synapses, and are not toxic but neuroprotective as they have an active role in synaptic regulation and are crucial for neuronal function. Aβ monomers are one of the many factors that regulate synaptic function and they can activate CREB via the PI3K/AKT pathway, leading to a sustained CREB-regulated transcription and release of BDNF. In this way, BDNF can act as a converging point of many synaptic regulators. In Alzheimer’s disease (AD), neurotoxic β-amyloid (Aβ) oligomers are formed from the self-association of Aβ monomers. These oligomers can promote neurotoxicity through different ways. suggested that the selective vulnerability of memory related areas could be, in fact, a result of specific cellular modifications required for the process of memory consolidation. An important event in AD is the pathogenic Aβ-mediated alterations in the levels of neurotrophic factors (NTFs). Since pathogenic Aβ oligomers cannot can activate PI3K/AKT pathway and induce CREB activation, the increase in the levels of Aβ-oligomers can lead to an impairment in CREB activation in the brain of patients with AD and mouse models of AD. Soluble Aβ oligomers are known to alter signal transduction pathways crucial for learning and memory processes such as CREB-regulated transcription and trafficking of NMDA type of glutamate receptors. Thus, alterations in those pathways could play an important role in the etiology of the disease. Altered levels of BDNF in AD are downstream of Aβ-accumulation and could be related to Aβ–induced dysregulation of CREB transcription. Even if BDNF does not modify Aβ accumulation, it could have an important function in moderating the effects of Aβ on cognitive and structural aspects. BDNF protects against Aβ-mediated toxicity by contributing to its degradation and preventing tau hyperphosphorylation. In this sense, BDNF is expressed by microglial and astroglial cells in the plaque vicinity and seems to protect from neuroinflammation, thereby supporting neuronal survival and preventing apoptosis. On the other side, Aβ down-regulates BDNF mRNA in vitro via reduction of CREB and disrupts retrograde axonal transport of BDNF and conversion of pro-BDNF to mature BDNF. It also interferes with synaptic plasticity mediated by BDNF even at concentrations that do not kill the cells. This downregulation occurs before the appearance of plaques and is linked to memory deficits in AD animal models and in MCI. Tau, a mediator of Aβ-induced toxicity, can significantly downregulate BDNF via transcript IV both in vitro and in vivo by itself. As mentioned before, many studies found that decreases in serum BDNF levels can be detected in individuals with MCI, so it is tempting to speculate that BDNF loss could be involved as an early event in this synaptic dysfunctions. However, the presence of some inconsistencies between studies with MCI patients warns us to be cautious with these speculations. Nevertheless, these results suggest a critical role of BDNF in the regulation of Aβ-amyloid toxicity, suggesting that BDNF dysregulation could contribute to synaptic dysfunction and mnemonic impairment related to AD. This data implies that, although central to the development of AD, changes in BDNF expression could be an effect of earlier functional modifications in other synaptic related proteins. In particular, one of these proteins could be Aβ, that in its monomeric form has a normal physiological role in synaptic plasticity and neuronal survival in the brain and can actually have an active role in these BDNF changes by regulating BDNF transcription and release. In any case, the beneficial effects of BDNF on memory and cognition could reflect its synapse repair features.

23Changes in the cell microenvironment, where a lack of trophic support can lead to a decrease in neuronal survival and proliferative activity, could contribute to the degeneration of specific neuronal subpopulations in pathological conditions. During this period, changes in BDNF levels contribute to age-related hippocampal volume changes, and atrophy associated with pathological conditions. There is evidence of as much as 1–2% annual hippocampal atrophy in the elderly without signs of dementia, while in patients with AD this deterioration goes up to 3–5% per year. In patients with MCI, hippocampal volume is predictive of rapid conversion to dementia, evidencing its importance in the progress of the disease.

24Most studies report that BDNF genotype is not related to the risk of developing AD [but see for evidences of effects present only in women], and Genome Wide Association Studies could not find a relationship between BDNF Val66Met polymorphism and risk of AD. However, some studies do report an increase in the risk for AD in Val carriers. Other studies found an association between Met carriers and greater rates of decline in episodic memory and hippocampal atrophy in patients with MCI, leaving Aβ accumulation unaffected. Although there are certain inconsistencies among the literature, BDNF role in the development of AD seen with Val66Met has been replicated with other BDNF polymorphisms. The lack of consistency between studies could be related to differential effects of BDNF during distinct stages of the disease, with more circulating BDNF in MCI patients, and less in AD patients. Lower BDNF levels may be linked to neuronal death in AD, concealing any effect of the BDNF gene. Since the complexity of the pathological changes stemming from the disease increases as the severity progresses, associations between BDNF Val66Met polymorphism and AD should be more obvious in preclinical stages in which the disease presents almost exclusively subtle alterations in mnemonic performance.

25Neurotrophic factors not only moderate neuronal and synaptic dysfunction but also cognitive decline in AD. Higher sBDNF is associated with a protection against future occurrence of dementia and AD and predictive of slower rates of decline. In the same manner, changes in BDNF levels induced pharmacologically or by aerobic exercise are related to better cognitive function and diminished synaptic dysfunction both in humans at risk of developing AD and in animal models of AD. These effects could be related to the ability of BDNF to prevent lesion-induced neuronal degeneration. According to this idea, post-lesion gene transfer of BDNF partially restored the deficits in learning capacity and synaptic plasticity in an AD model in which BoNTx-induced damage to the entorhinal cortex was used to mimic AD pathology. Neural stem cell transplants or CREB binding protein gene transfers reversed spatial memory deficit via BDNF in AD mouse models, despite widespread Aβ plaque and tau pathology. In a recent study, delivery of BDNF to the entorhinal cortex in amyloid transgenic mice reversed neuronal atrophy and synaptic loss, regulated neuronal signaling, and diminished the related mnemonic deficits without changes in the amyloid plaque load indicating that BDNF can act through amyloid-independent mechanisms to exert its protective effect. Furthermore, 7,8-dihydroflavone (7,8-DHF), Neotrofin (a hypoxanthine derivative that stimulates neurotrophic factor production) and Neuropep-1 (a BDNF modulating peptide) have shown to reverse memory deficits in animal models of AD or even in preclinical trials. In this way, BDNF could mediate the protective effect of exercise and caloric restriction on neurodegeneration. This strengthens the need to develop behavioral interventions that could prevent the risk of developing dementia or slow the progression to dementia in patients with MCI, a path that is currently in progress. Many of these new paths point to lifestyle changes that range from antioxidant diet, environmental enrichment and social interaction to physical or cognitive exercise as potential interventions.

The Effect of Chronic Stress on BDNF and the Link to Psychiatric Disorders

26Chronic stress is a known factor involved in the incidence of AD and cognitive impairment. Structures involved in the control of the physiological status of an organism are susceptible to modulation by chronic stress. In particular, the hippocampus is altered by prolonged exposure to aversive situations. These abnormalities are reflected in deficits in spatial memory tasks and novel object recognition, but also in altered synaptic plasticity processes like suppression of LTP. Chronic stress typically decreases BDNF hippocampal expression, however, when the cause of the stress disappears, the hippocampus shows amelioration of the cognitive and synaptic deficits.

27To this date, a wide variety of strategies have been assessed to reduce the deleterious effects caused by chronic stress. Infusions of BDNF in the rat hippocampus before a chronic restraint stress protocol can protect against the deficits in learning and memory in the MWM and in LTP and shRNA against BDNF before a stress protocol can revert the spatial reference memory deficits during the post-stress-rest period.

28Exercise, is a well-known strategy to increase BDNF brain levels, so it has been proposed as a non-invasive way to mimic the effects of direct BDNF administration over chronic stress. found that the hippocampal BDNF increases in response to exercise after a chronic stress protocol. On the other hand, showed that animals that followed a 30 days swimming training program improved their performance in the T maze after being exposed to chronic stress and this enhancement correlated with upregulation of hippocampal BDNF. Also, described a BDNF-mediated improvement in MWM performance in chronically stressed mice that started treadmill running 12 weeks before the beginning of the stress protocol and continued throughout it.

29investigated the palliative effects of exercise (alone or combined with fluoxetine) on a rat model of post-traumatic stress disorder. This model shows impairments in fear conditioning and extinction, inhibitory avoidance task and location recognition memory. Interestingly, in most tests, the effects of the combined treatment were similar to the ones obtained with exercise alone. They also found, in agreement with the work of, that exercise alone and exercise plus antidepressant enhanced hippocampal BDNF expression, but not antidepressant alone.

30Enriched environment (EE) has been shown to increase BDNF levels in the hippocampus in comparison with standard housing conditions. Thus, EE could be an easy way to promote the systemic and neural recovery from the effects of chronic stress. showed that exposure to EE following 10 days of immobilization (2 h/day) ameliorates spatial memory deficits in a version of the radial arm maze and depressive-like behavior. Recovery seems to be achieved through the modulation of several signaling cascades, including BDNF’s.

31suggested that EE is as effective as Fluoxetine when it occurs after exposure of the animals to a chronic stress protocol, but additional measures of the effectiveness of the stress protocol would be needed to establish the success of the treatment. Interestingly, BDNF levels were increased in the hippocampus of rats that receive either EE or Fluoxetine in comparison with the control group (stressed but without posterior treatment). Considering that chronic stress is linked to depressive-like symptoms, the results obtained using antidepressants do not seem surprising. The mechanisms of antidepressant actions over chronic stress and the putative involvement of BDNF have also been extensively studied but with no consistent results yet. showed that chronic antidepressant treatment reversed depressive-like behavior caused by chronic unpredictable stress-induced and increased BDNF mRNA expression in the granular cell layer of the dorsal hippocampus (independently of exposure to stressors). Using a different stress model, were able to normalize behavioral alterations in mice exposed to a social defeat stress protocol followed by chronic (but not acute) administration of imipramine They proposed a model in which chronic stress induces repression and chronic imipramine induces de-repression of the bdnf gene in the hippocampus through changes in the chromatin structure.

32Some studies are focusing in compounds that have been originally used to treat other diseases but have shown some antidepressant effects in animal models, such as resveratrol. Resveratrol and curcumin, when chronically administrated, prevent the behavioral and biochemical alterations induced by chronic restraint and unpredictable stress, respectively, and those effects seem to be mediated by an increment in the expression of BDNF. show that biperiden alleviates depression-like symptoms induced by chronic unpredictable stress, increasing performance in the sucrose preference, novelty suppression feeding and forced swimming tests. Importantly, these effects were inhibited by pretreatment with the TrkB antagonist K252a.

33Since the evidence suggests that BDNF may drive the recovery from stress-induced effects on the hippocampus, an interesting question emerges: Is BDNF capable of reversing the effects of chronic stress in the presence of the stressor?

34tested the effect of exercise during the exposure to stressors (“protective exercise”). Unlike preventive and therapeutic exercise, no increment on BDNF hippocampal levels was found. On the other hand, explored, in mice, the potential palliative effects of running on chronic stress-related impairments when exercise and stress are co-occurring. They found that the TrkB receptor had higher expression levels in both exercised groups (stressed and non-stressed) compared with both sedentary groups, supporting the hypothesis that the mitigation of the negative consequences of stress by exercise could be mediated by BDNF.

35Depending on the chronic stress protocol (duration and type of stressor), different and even contrasting results have been found. BDNF appears to be an important underlying molecule behind the restitution of a normal cognitive phenotype in animal models of chronic stress. The fact that BDNF could be increased with non-invasive protocols and/or drugs -some of which are used in clinical trials- makes it attractive for human therapies.

36The link between stress, specific genes and the development of psychiatric disorders has been extensively studied, and a causal role has been ascribed of gene-environment interactions in the etiology of many of them. In fact, psychiatric disorders can be defined as clinical entities emerging from the genetic-environmental interaction (for review, ).

Psychiatric Disorders and BDNF

37In the last few years, evidence from animal models and clinical studies strongly suggest that dysregulation of neurotrophic factors could play an important role in the etiology of the bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SZ). Due to the role of BDNF in neural plasticity, there could be a link between BDNF expression and the cognitive symptoms associated with memory impairments.

38The mnemonic domain is commonly affected in different psychiatric disorders, such as BD, MDD, or SZ. Moreover, studies of post-mortem brain tissue of patients with BD and MDD reported that BDNF levels are decreased in structures involved in memory processes, such as the hippocampus and the prefrontal cortex. In the case of SZ, post-mortem brain tissue analyses have shown more controversial results. While some studies observed an increase in BDNF expression in the prefrontal cortex and the hippocampus, others have shown a decrease in both structures. Although BDNF was originally thought as a viable indicator of pathological brain functioning for early detection of BD, MDD, SZ, or AD, the discriminative power of BDNF as a biomarker is highly limited, since it seems to be a non-specific marker of many neuropsychiatric disorders.

39The BD is a neuropsychiatric disorder that emerges from the interaction between genetic and environmental factors and is characterized by the switching between maniac and depressive episodes (for review, ). It has been proposed that BDNF signaling participates in the physiological effects produced by some pharmacological treatments used for BD. It has been shown that sBDNF decreases in the first episode of unmedicated BD patients and that, after 1-year of pharmacological intervention, sBDNF concentration increases. in addition, there was a a negative correlation between the number of episodes and sBDNF levels. It has been reported that sBDNF positively correlates with the duration of the maniac and depressive episodes. This evidence suggests that episode-related changes in the structure of the brain could be linked to peripheral BDNF concentration. have shown that hippocampal volume is reduced in patients with BD that present Val66Met BDNF polymorphism compared with controls and patients with MDD. Moreover, they proposed a link between the hippocampal volume and the performance in an episodic memory task. Another work has shown that the peripheral BDNF correlates with the performance in episodic memory task in BD patients with the BDNF Val66Met polymorphism. In this line, a recent study has shown that high levels of sBDNF are associated with good cognitive performance, including verbal memory. This evidence suggests that changes in BDNF expression in BD patients could produce structural modifications in the hippocampal formation related to episodic memory impairments. Despite this, most of the studies report alterations in other cognitive domains that are important for a good performance in episodic memory tasks, such as attention and working memory (for review, ). Thus, BDNF dysregulations could be related with the emergence of more complex symptom’s profiles. For this reason, the relationship between BDNF and episodic memory in BD remains unclear.

40Major depressive disorder is one of the most common mood disorders worldwide and is characterized by the absence of pursuit of pleasurable activities and the presence of negative thoughts. Since most common drugs used as antidepressant block the serotonin transporter (SERT), increasing extracellular serotonin in the raphe’s nucleus post-synapses (for review, ), it has been proposed that a misbalance in the serotonergic release could be related to the etiology of the depressive symptoms (for review, ). BDNF regulates the growth and reconstruction of 5-HT containing neuronal terminals in the cortex, and administration of BDNF in the raphe nucleus reduces behaviors related to depressive symptoms in rats. In addition, MDD patients present cognitive decline in different domains, including episodic memory but only recently these deficits have been studied in detail. A large amount of work shows that sBDNF is decreased in MDD. found that patients that recurrently present depressive episodes show lower levels of sBDNF compared with those patients that were cursing their first episode. Interestingly, antidepressant treatment increases sBDNF concentration, but there is no consensus on whether lower sBDNF correlate with poor performance in memory tasks observed in this pathology.

41In the case of the SZ, different studies have shown that the level of sBDNF correlates with cognitive performance in different domains. Despite the lack of consensus on whether basal sBDNF is increased or decreased in SZ patients, some studies have indicated a correlation between memory performance and sBDNF levels. Interestingly, there are evidences that pro-cognitive effects of pharmacological interventions in SZ could be mediated by BDNF. For example, have found that a 12-week chronic treatment with olanzapine produced an increase in BDNF plasma concentration. Moreover, BDNF concentration positively correlated with cognitive performance in a RBANS scale of memory. Not only the pharmacological interventions were effective on the reduction of mnemonic symptoms, different cognitive training protocols were also designed to enhance specific cognitive domains, especially memory. conducted a computerized cognitive training in SZ patients and the patients exposed to this program present higher levels of sBDNF compared to the control group. They observed an enhancement in memory, but a causal link between sBDNF and memory remains unclear.

BDNF as a Potential Mediator Underlying the Benefits of Therapeutic Strategies

42Considering all the results mentioned above, it would be tempting to suggest the use of BDNF as a therapeutic target for both age-related and neuropsychiatric-related cognitive dysfunction. This idea has found many difficulties to be put to practice because of the poor brain barrier penetration of BDNF and short half-life on plasma. Moreover, gene therapy and BDNF mimetic strategies came across many negative side effects that led to their abandonment. Clinically plausible alternative approaches could include a natural increase the production of endogenous BDNF. In this sense, epidemiological studies have suggested that a number of lifestyle factors such as physical exercise, diet and social activity and education may reduce the long-term risk of cognitive impairment and dementia, and animal studies are consistent with this idea.

43In particular, the risk of developing AD is highly increased in a lonely person, indicating that social interaction could delay the onset of the disease. Physical activity is another lifestyle factor that could influence the progress of the disease. Recent reports from both epidemiological and interventional studies reinforce the idea of using physical activity as a strategy to increase neuroplasticity in pathological conditions. The influence of behaviors such as exercise and social interaction on learning and memory processes has been thoroughly studied. Researchers have found a relationship between frequent social activity and improved cognitive function. In the same direction, the cognitive improvement due to physical exercise has also been well documented. Physical exercise has shown not only to ameliorate structural changes in the brain, but also to protect against aging-related cognitive decline.

44Considering that lifestyle implementations have the ability to impact in the brain, a central question is how these changes in energy metabolism and social stimuli can impact on the brain structure and interact with synaptic plasticity and molecular systems to improve cognitive function.

45A current model explains the effects of these lifestyle factors in terms of changes in vasculature and neurotrophic and neurotransmitter-support system. Of all these changes, BDNF is the only one that is present in all the aforementioned lifestyle manipulations. BDNF is increased by social interaction with conspecifics in APP/PS1 mice, leading to the reversal of memory deficits. Also, BDNF could be important for the regulation of energy homeostasis, since diminished BDNF levels are associated with disorders of energy metabolism such as obesity and hyperglycemia. In fact, a high fat diet was shown to decrease BDNF levels in the hippocampus and impair learning and memory. Additionally, the increase in BDNF is one of the most consistent changes reported following exercise, as recently discussed in a meta-review. The most robust experiments supporting the fundamental role of BDNF in exercise-induced improvement in cognitive function are the ones in which blockade of BDNF impaired the cognitive improvements induced by exercise. showed that the exercise-induced enhancement of learning in the MWM task was blocked by TrkB-IgG administrated during the exercise period. Furthermore, exercise enabled the acquisition of sub threshold experiences (object location memory task) and this effect was dependent on BDNF. A similar effect was reported by using BDNF siRNA to diminish BDNF function.

46For its practicality, physical activity is the lifestyle change with more potential as a therapeutic/prevention strategy. A bulk of studies have focused on the idea of aerobic exercise as a potential non-pharmacological and low cost treatment to maintain and improve neurocognitive function. A meta-analysis of several longitudinal training studies showed that exercise improved cognitive function regardless of the task type. Recent studies confirmed this effect showing that not only spatial or contextual hippocampal dependent- memory tasks improve with exercise, but also non-spatial memories such as object recognition that are thought to rely more heavily on the Prh than the HP. A single session of cardiovascular exercise benefits long-term memory but does not influence short-term memory. Moreover, exercise can improve memory in aged animals specifically during a restricted time window after the experience, reinforcing the specific role of exercise over the memory consolidation process. Interestingly, many studies found that sex may be an important variable when evaluating the effectiveness of exercise interventions and this is consistent with the sex-specific mechanisms of action of BDNF. The timing of the intervention could also be relevant. In several models of traumatic neurological injury, when interventions are given prior to the damage, induction of BDNF reduced neuronal degeneration and improved cognitive outcome. Although the effects of exercise are somewhat short-lived, some interventions can improve the outcome even when given after the damage. However, the duration of the benefits depends on the age of the subject during the exercise exposure. While adolescent exercise training did not affect BDNF levels immediately after an object recognition task, it did lead to greater BDNF levels in the Prh if the task was done 2 weeks after. In adulthood, exercise increased BDNF levels immediately after the task but this effect was short-lived and lasted less than 2 weeks. These data suggest that exercise could modulate learning related plastic changes in an age-dependent manner. Although the benefits of exercise are related to many growth factors, BDNF is the only one consistently elevated after a few weeks of continuous exercise. This neurotrophin is rapidly induced in the hippocampus and cortical regions, and remains elevated for several days after exercise. In addition, BDNF levels can be rapidly re-induced up to peak levels by a subsequent sub threshold exposure to exercise, even several days after the end of the exercise program.

47Exercise does not influence brain regions uniformly, but affects them in a more selective way, which suggests location-specificity of the molecular pathways involved in exercise-induced plasticity. Interestingly, the effects of exercise on BDNF expression occur in regions related to mnemonic functions such as the anterior hippocampus, cerebellum and frontal cortex, but not others such as the striatum. This is in accordance with previous reports indicating that exercise-induced increases in sBDNF levels are associated with changes in hippocampal volume, which, in turn, correlate with spatial memory performance.

48The positive effects of exercise on plasticity are particularly relevant for the aging population, in which BDNF levels are decreased. Considering that the aging brain is still capable of plasticity, lifestyle related experiences could be a way to recruit plastic processes and counteract the detrimental effects of aging. In aged animals, hippocampal neurogenesis and BDNF levels can increase with exercise. Although these effects are not as robust as those seen in younger animals, the increase in BDNF seems to ameliorate mental deterioration and improve memory function. In fact, long-term exercise programs are able to rescue these cognitive deficits even after the first signs of mnemonic impairment. A recent clinical trial examined the impact of aerobic cardiorespiratory training versus stretching on MCI patients and reported sex-dependent cognitive improvements related with trophic factor and Ab-40 and Ab-42 circulating levels.

49Physical activity is also associated with a lower risk of developing dementia. Many clinical trials point toward improved cognition and reduced incidence of psychiatric symptoms when patients with mild AD received a physical training protocol. However, some studies suggest that environmental enrichment could be more beneficial for cognition than physical exercise alone.

50Coordinative exercise and cognitive training can also induce gray matter plasticity and enhance cognitive functions in older adults. However, the improvement generated by prior training is usually domain-restrictive and only acts over memory systems affected by the previous experience. Nonetheless, there are some reports that show a generalized benefit of prior experience to different tasks and contexts. A combination of physical and cognitive training with control of nutritional and cardiovascular risk factors during a 2-year period led to improved cognitive performance in old adults at risk of developing dementia. In animal studies, environmental enrichment could be seen as a multidomain intervention. It consists of social enrichment, physical exercise and environmental changes and has been shown to increase BDNF levels and enhance learning and memory in different domains such as object recognition, spatial learning and motor abilities. The combination of both sensory enrichment and physical activity has more impact on neuronal plasticity than these elements given independently. This motivated original therapeutical proposals in human research. For example, a novel dancing program with higher cognitive and coordinative demands than previous physical activity programs induced more gray matter increases in an aged group than a traditional sport program with comparable cardiovascular demands.

51One important question regarding the effects of exercise on cognitive function is to establish the mechanisms responsible for the cross talk between cardiovascular/muscle activity and the central nervous system. The muscle higher metabolic rates could lead to the secretion of signaling molecules, that could subsequently upregulate plasticity related gene expression and protect the brain from damage. In this way, elevated plasticity molecules such as BDNF could prime the brain to be better prepared for subsequent changes related to learning or could be selectively secreted in an activity-dependent manner during learning experiences. As a result, exercise could enhance the activity of a general molecular machinery important for learning and memory. In accordance with this view, molecules such as CREB, NMDARs subunits and BDNF are particularly induced following exercise and brain regions important for memory formation such as the hippocampus are selectively influenced by physical activity.

52A potential mechanism for the exercise-related neuroprotective effects of BDNF is via modulation of synaptic and structural plasticity. Plastic changes induced by exercise include increased neurogenesis, greater arborization of neuronal dendrites and synaptogenesis, as well as increased amplitude and reduced threshold for LTP. Since these effects are accompanied by a concurrent increase in BDNF levels, BDNF could be a potential mediator. In addition, increased vascularization accompanied by greater dendritic complexity and neurogenesis could explain the increase in hippocampal volume following exercise. The progressive age-related decline in neurogenesis has been associated with a non-permissive microenvironment with low levels of neurogenesis-promoting factors. However, this microenvironment is still responsive to environmental changes and can be stimulated even at late stages to provide molecular cues for proliferation. Changes in growth factor levels such as BDNF might underlie the decrease in neurogenesis seen as a consequence of disease or aging, and the aged brain retains the capacity to respond to the neurogenesis-stimulating effects of growth factors.

53Exogenous application of BDNF can restore the levels of hippocampal neurogenesis in aged animals. In the same way, exercise-induced increases in neurogenesis are necessary for the physical activity-dependent enhancement in learning and memory. This led to the idea that neurogenesis could be the substrate of this cognitive enhancements mediated by BDNF.

54Another potential beneficial effect of BDNF is its ability to protect neurons from oxidative damage or excitotoxic stress and from Aβ-induced degeneration in animal models of normal and pathological aging. In fact, BDNF is upregulated in response to different kinds of insults to the nervous system. An exercise regime can lessen the accumulation of oxidative cell damage and the dysfunction characteristic of aged animals, and selective suppression of BDNF increases the vulnerability of neurons to excitotoxicity and increases amyloidogenesis.

55Although there should be a clear excitement to establish a systematic exercise program to ameliorate or even prevent symptoms of memory deficits related to aging, psychiatric disorders or diseases, many limitations still exist for this therapeutic line. One of the most important drawbacks of this approach is that the high prevalence of chronic diseases in the aged population affects exercise performance and feasibility, increasing the potential risks of the treatment, especially for high intensity protocols. This directly impacts on the motivation to follow these kinds of treatments, which are known to have low adherence. Programs with lower intensities could be a better choice, since they are still able to impact positively on cognition and neurophysiology in aged subjects without affecting adherence to the treatment. It has been reported that the lack of time is also one of the main reasons for avoiding regular practice of aerobic exercise. Thus, there is interest in developing more efficient training programs involving less time demand but inducing a similar BDNF response. demonstrated, in animals, that the practice of low/moderate intensity aerobic exercise through 2 to 18 months of life increased BDNF in various brain structures like the prefrontal cortex and the hippocampus and reduces the normal decline due aging. Moreover, this protocol improved both novel object recognition and context discrimination capacity. conducted a meta-analysis to determine the impact of acute and regular exercise on BDNF levels in humans. They found that the moderate effect from a single session of exercise was intensified if it was executed after a regular program of exercise. They posit that each episode of exercise results in a “dose” of BDNF activity and that the magnitude of this “dose” can be enhanced over time by regular exercise.

56On the other side, attempts to directly use recombinant BDNF as a therapy have found many methodological limitations. One of the main problems for translating BDNF-based therapies into the clinic is problem of delivery to the brain and the challenge of sustaining the expression for longer intervals since since the recombinant protein has a very short half-life. In this sense, some preclinical studies were oriented to using BDNF fused to cell-penetrating peptides and packed in AAV-constructs and intranasal delivery of these AAV constructs to central nervous system. A10-day-AAV treatment could alleviate depression-like behaviors in mice, and AAV delivery of BDNF striatal neurons induced neurogenesis and increased the lifespan of an animal model of HD. Although beneficial, the use of AAV has been limited by difficulties in biodistribution and the immunogenicity to the virus. An alternative approach is the use of stem cell transplants that can express BDNF and other beneficial factors and can migrate into damaged areas of the brain by their selective tropism to inflammation and apoptosis sites, although they are not permanently integrated into the organism. Mesenchymal stem cell transplantations have shown improvements in behavioral deficits in a murine model of HD, have also slowed the neurodegenerative processes by a diminished atrophy and an increased neurogenesis.

57An alternative possibility to the use of exercise as a ‘natural’ and non-invasive way of increasing BDNF signaling in neuronal networks, is the administration of drugs already available for clinical use. Many medications are capable of impacting on BDNF levels. Memantine and donepezil are a pharmaceutical compound used to alleviate the symptoms of AD that markedly increases BDNF levels in a dose-dependent manner.

58Ampakines are good candidates because they can increase excitatory transmission affecting BDNF levels. In rat hippocampal slice cultures, a very brief clinically tested ampakine treatment produced elevated BDNF protein levels that lasted several days after the exposure. Another therapeutic possibility that has emerged recently is the use of transcranial magnetic stimulation (TMS) to increase BDNF levels. TMS restored the levels of BDNF and TrkB that were normally reduced in aged mice and improved spatial memory.

59In conclusion, several environmental and lifestyle interventions that reduce age-dependent cognitive decline and pathological degeneration can also increase BDNF production, suggesting that BDNF is neuroprotective (Figure 1). Given that cognitive training is a focused approach that selectively acts on sets of memory domains and that drugs are invasive, exercise is still a ‘favorite’ when thinking of potential therapeutic approaches.

Conclusion

60Although BDNF is a key player in synaptic plasticity and memory process, its role in the etiology of cognitive symptoms in pathological conditions remains unclear. BDNF-mediated plastic changes have been proposed as one of the underlying neurobiological substrates of memory consolidation, and changes in BDNF were shown to directly affect memory performance in animal models of neurodegenerative/neuropsychiatric diseases and in normal conditions. In human post-mortem brain tissue, BDNF expression is higher in memory related structures, such as the hippocampus and the amygdala. However, in humans, the relationship between memory and BDNF still remains correlational, mainly because the available techniques do not allow the control of BDNF expression in humans. Despite this difficulty, numerous studies attempted to establish causal relationships between these two factors by analyzing memory performance under conditions that up-regulate or down-regulate BDNF expression. Since brain BDNF expression correlates with sBDNF concentration, this association has been extensively used to study the implication of BDNF in mnemonic functions in humans under normal and pathological conditions. In fact, the concentration of this blood-measurable protein is correlated with the memory impairment in different disorders. Additionally, changes in the trafficking and release of BDNF due to Val66Met polymorphism have also been used to correlate BDNF levels with mnemonic performance and structural changes in memory-related regions in healthy and diseased individuals. It has been shown that interventions such as exercise, chronic administration of fluoxetine, and cognitive training can enhance the sBDNF concentration and correlates with a better performance in memory tasks. The initial idea of using BDNF as a biomarker for neurodegenerative/neuropsychiatric diseases was discarded because changes in BDNF levels are common to many pathological conditions, which underscores its discriminative value and potency. However, considering the data reviewed here, we suggest that BDNF can be thought of as a marker that specifically relates to the occurrence and/or progression of the mnemonic symptoms that are common to many pathological conditions that share deficits in this cognitive domain. Moreover, BDNF was shown to be a shared factor in which converge most of the therapies that have been able to fight these mnemonic symptoms.

Author Contributions

61MM was responsible for drafting the manuscript and revising its content. JM and MZ contributed to writing the manuscript and figure design. PB was responsible for the general idea, writing and critically revising, and correcting the manuscript. All authors read and approved the final manuscript, and contributed to the conception of the work.

Conflict of Interest Statement

62The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 425

1.
Dief A. E. Samy D. M. Dowedar F. I. (2015 ). Impact of exercise and vitamin B1 intake on hippocampal brain-derived neurotrophic factor and spatial memory performance in a rat model of stress. J. Nutr. Sci. Vitaminol. 61 1–7.
Not in our library10.3177/jnsv.61.1 (opens in a new tab)
2.
Abbott P. W. Gumusoglu S. B. Bittle J. Beversdorf D. Q. Stevens H. E. (2018 ). Prenatal stress and genetic risk: how prenatal stress interacts with genetics to alter risk for psychiatric illness. Psychoneuroendocrinology 90 9–21.
Not in our library10.1016/j.psyneuen.2018.01.019 (opens in a new tab)
3.
Abramov E. Dolev I. Fogel H. Ciccotosto G. D. Ruff E. Slutsky I. (2009 ). Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat. Neurosci. 12 1567–1576.
Not in our library10.1038/nn.2433 (opens in a new tab)
4.
Adlard P. A. Perreau V. M. Pop V. Cotman C. W. (2005 ). Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J. Neurosci. 25 4217–4221.
Not in our library10.1523/jneurosci.0496-05.2005 (opens in a new tab)
5.
Ahern E. Semkovska M. (2017 ). Cognitive functioning in the first-episode of major depressive disorder: a systematic review and meta-analysis. Neuropsychology 31 52–72.
Not in our library10.1037/neu0000319 (opens in a new tab)
6.
Alaei H. Moloudi R. Sarkaki A. R. Azizi-Malekabadi H. Hanninen O. (2007 ). Daily running promotes spatial learning and memory in rats. J. Sports Sci. Med. 6 429–433.
Not in our library
7.
Albeck D. S. Sano K. Prewitt G. E. Dalton L. (2006 ). Mild forced treadmill exercise enhances spatial learning in the aged rat. Behav. Brain Res. 168 345–348.
Not in our library10.1016/j.bbr.2005.11.008 (opens in a new tab)
8.
Almeida R. D. Manadas B. J. Melo C. V. Gomes J. R. Mendes C. S. Graos M. M. (2005 ). Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 12 1329–1343.
Not in our library10.1038/sj.cdd.4401662 (opens in a new tab)
9.
Alonso M. Medina J. H. Pozzo-Miller L. (2004 ). ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn. Mem. 11 172–178.
Not in our library10.1101/lm.67804 (opens in a new tab)
10.
Ando S. Kobayashi S. Waki H. Kon K. Fukui F. Tadenuma T. (2002 ). Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine. J. Neurosci. Res. 70 519–527.
Not in our library10.1002/jnr.10443 (opens in a new tab)
11.
Apple D. M. Solano-Fonseca R. Kokovay E. (2017 ). Neurogenesis in the aging brain. Biochem. Pharmacol. 141 77–85.
Not in our library10.1016/j.bcp.2017.06.116 (opens in a new tab)
12.
Arregui L. Benitez J. A. Razgado L. F. Vergara P. Segovia J. (2011 ). Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington’s disease delays the onset of the motor phenotype. Cell Mol. Neurobiol. 31 1229–1243.
Not in our library10.1007/s10571-011-9725-y (opens in a new tab)
13.
Arshavsky Y. I. (2006 ). Alzheimer’s disease, brain immune privilege and memory: a hypothesis. J. Neural Transm. 113 1697–1707.
Not in our library10.1007/s00702-006-0524-4 (opens in a new tab)
14.
Artola A. Von Frijtag J. C. Fermont P. C. Gispen W. H. Schrama L. H. Kamal A. (2006 ). Long-lasting modulation of the induction of LTD and LTP in rat hippocampal CA1 by behavioural stress and environmental enrichment. Eur. J. Neurosci. 23 261–272.
Not in our library10.1111/j.1460-9568.2005.04552.x (opens in a new tab)
15.
Assuncao M. Santos-Marques M. J. Carvalho F. Andrade J. P. (2010 ). Green tea averts age-dependent decline of hippocampal signaling systems related to antioxidant defenses and survival. Free Radic. Biol. Med. 48 831–838.
Not in our library10.1016/j.freeradbiomed.2010.01.003 (opens in a new tab)
16.
Autry A. E. Monteggia L. M. (2012 ). Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64 238–258.
Not in our library10.1124/pr.111.005108 (opens in a new tab)
17.
Baker K. B. Kim J. J. (2002 ). Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats. Learn. Mem. 9 58–65.
Not in our library10.1101/lm.46102 (opens in a new tab)
18.
Baker L. D. Frank L. L. Foster-Schubert K. Green P. S. Wilkinson C. W. Mctiernan A. (2010 ). Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch. Neurol. 67 71–79.
Not in our library10.1001/archneurol.2009.307 (opens in a new tab)
19.
Balkowiec A. Katz D. M. (2000 ). Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J. Neurosci. 20 7417–7423.
Not in our library10.1523/jneurosci.20-19-07417.2000 (opens in a new tab)
20.
Barha C. K. Galea L. A. Nagamatsu L. S. Erickson K. I. Liu-Ambrose T. (2017 ). Personalising exercise recommendations for brain health: considerations and future directions. Br. J. Sports Med. 51 636–639.
Not in our library10.1136/bjsports-2016-096710 (opens in a new tab)
21.
Barker P. A. (2009 ). Whither proBDNF? Nat. Neurosci. 12 105–106.
Not in our library10.1038/nn0209-105 (opens in a new tab)
22.
Barnes C. A. (1994 ). Normal aging: regionally specific changes in hippocampal synaptic transmission. Trends Neurosci. 17 13–18.
Not in our library10.1016/0166-2236(94)90029-9 (opens in a new tab)
23.
Bartko S. J. Winters B. D. Cowell R. A. Saksida L. M. Bussey T. J. (2007 ). Perirhinal cortex resolves feature ambiguity in configural object recognition and perceptual oddity tasks. Learn. Mem. 14 821–832.
Not in our library10.1101/lm.749207 (opens in a new tab)
24.
Bartolotti N. Segura L. Lazarov O. (2016 ). Diminished CRE-induced plasticity is linked to memory deficits in familial Alzheimer’s disease mice. J. Alzheimers Dis. 50 477–489.
Not in our library10.3233/jad-150650 (opens in a new tab)
25.
Basak C. Boot W. R. Voss M. W. Kramer A. F. (2008 ). Can training in a real-time strategy video game attenuate cognitive decline in older adults? Psychol. Aging 23 765–777.
Not in our library10.1037/a0013494 (opens in a new tab)
26.
Bath K. G. Lee F. S. (2006 ). Variant BDNF (Val66Met) impact on brain structure and function. Cogn. Affect. Behav. Neurosci. 6 79–85.
Not in our library10.3758/cabn.6.1.79 (opens in a new tab)
27.
Bekinschtein P. Cammarota M. Igaz L. M. Bevilaqua L. R. Izquierdo I. Medina J. H. (2007 ). Persistence of long-term memory storage requires a late protein synthesis- and BDNF- dependent phase in the hippocampus. Neuron 53 261–277.
Not in our library10.1016/j.neuron.2006.11.025 (opens in a new tab)
28.
Bekinschtein P. Oomen C. A. Saksida L. M. Bussey T. J. (2011 ). Effects of environmental enrichment and voluntary exercise on neurogenesis, learning and memory, and pattern separation: BDNF as a critical variable? Semin. Cell Dev. Biol. 22 536–542.
Not in our library10.1016/j.semcdb.2011.07.002 (opens in a new tab)
29.
Benraiss A. Bruel-Jungerman E. Lu G. Economides A. N. Davidson B. Goldman S. A. (2012 ). Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF. Gene Ther. 19 483–493.
Not in our library10.1038/gt.2011.114 (opens in a new tab)
30.
Benraiss A. Toner M. J. Xu Q. Bruel-Jungerman E. Rogers E. H. Wang F. (2013 ). Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington’s disease. Cell Stem Cell 12 787–799.
Not in our library10.1016/j.stem.2013.04.014 (opens in a new tab)
31.
Berchtold N. C. Chinn G. Chou M. Kesslak J. P. Cotman C. W. (2005 ). Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus. Neuroscience 133 853–861.
Not in our library10.1016/j.neuroscience.2005.03.026 (opens in a new tab)
32.
Bibel M. Hoppe E. Barde Y. A. (1999 ). Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J. 18 616–622.
Not in our library10.1093/emboj/18.3.616 (opens in a new tab)
33.
Blurton-Jones M. Kitazawa M. Martinez-Coria H. Castello N. A. Muller F. J. Loring J. F. (2009 ). Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 106 13594–13599.
Not in our library10.1073/pnas.0901402106 (opens in a new tab)
34.
Bramham C. R. Messaoudi E. (2005 ). BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 76 99–125.
Not in our library10.1016/j.pneurobio.2005.06.003 (opens in a new tab)
35.
Brown B. M. Bourgeat P. Peiffer J. J. Burnham S. Laws S. M. Rainey-Smith S. R. (2014 ). Influence of BDNF Val66Met on the relationship between physical activity and brain volume. Neurology 83 1345–1352.
Not in our library10.1212/wnl.0000000000000867 (opens in a new tab)
36.
Bruce-Keller A. J. Umberger G. Mcfall R. Mattson M. P. (1999 ). Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45 8–15.
Not in our library10.1002/1531-8249(199901)45:1<8::aid-art4>3.3.co;2-m (opens in a new tab)
37.
Buckner R. L. (2004 ). Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 44 195–208.
Not in our library10.1016/j.neuron.2004.09.006 (opens in a new tab)
38.
Budni J. Bellettini-Santos T. Mina F. Garcez M. L. Zugno A. I. (2015 ). The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease. Aging Dis. 6 331–341.
Not in our library10.14336/ad.2015.0825 (opens in a new tab)
39.
Buhusi M. Etheredge C. Granholm A. C. Buhusi C. V. (2017 ). Increased hippocampal proBDNF contributes to memory impairments in aged mice. Front. Aging Neurosci. 9:284.
Not in our library10.3389/fnagi.2017.00284 (opens in a new tab)
40.
Burke S. N. Barnes C. A. (2006 ). Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 7 30–40.
Not in our library10.1038/nrn1809 (opens in a new tab)
41.
Burke S. N. Wallace J. L. Hartzell A. L. Nematollahi S. Plange K. Barnes C. A. (2011 ). Age-associated deficits in pattern separation functions of the perirhinal cortex: a cross-species consensus. Behav. Neurosci. 125 836–847.
Not in our library10.1037/a0026238 (opens in a new tab)
42.
Burke S. N. Wallace J. L. Nematollahi S. Uprety A. R. Barnes C. A. (2010 ). Pattern separation deficits may contribute to age-associated recognition impairments. Behav. Neurosci. 124 559–573.
Not in our library10.1037/a0020893 (opens in a new tab)
43.
Buschkuehl M. Jaeggi S. M. Hutchison S. Perrig-Chiello P. Dapp C. Muller M. (2008 ). Impact of working memory training on memory performance in old-old adults. Psychol. Aging 23 743–753.
Not in our library10.1037/a0014342 (opens in a new tab)
44.
Caccamo A. Maldonado M. A. Bokov A. F. Majumder S. Oddo S. (2010 ). CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 107 22687–22692.
Not in our library10.1073/pnas.1012851108 (opens in a new tab)
45.
Cacquevel M. Launay S. Castel H. Benchenane K. Cheenne S. Buee L. (2007 ). Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiol. Dis. 27 164–173.
Not in our library10.1016/j.nbd.2007.04.004 (opens in a new tab)
46.
Calabrese F. Guidotti G. Racagni G. Riva M. A. (2013 ). Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor. Neurobiol. Aging 34 2768–2776.
Not in our library10.1016/j.neurobiolaging.2013.06.014 (opens in a new tab)
47.
Calabrese F. Molteni R. Racagni G. Riva M. A. (2009 ). Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34(Suppl. 1), S208–S216.
Not in our library10.1016/j.psyneuen.2009.05.014 (opens in a new tab)
48.
Caldeira M. V. Melo C. V. Pereira D. B. Carvalho R. F. Carvalho A. L. Duarte C. B. (2007 ). BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol. Cell Neurosci. 35 208–219.
Not in our library10.1016/j.mcn.2007.02.019 (opens in a new tab)
49.
Cammisuli D. M. Innocenti A. Fusi J. Franzoni F. Pruneti C. (2018 ). Aerobic exercise effects upon cognition in Alzheimer’s Disease: a systematic review of randomized controlled trials. Arch. Ital. Biol. 156 54–63.
Not in our library10.12871/00039829201816 (opens in a new tab)
50.
Cao B. Bauer I. E. Sharma A. N. Mwangi B. Frazier T. Lavagnino L. (2016 ). Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele. J. Affect. Disord. 198 198–205.
Not in our library10.1016/j.jad.2016.03.044 (opens in a new tab)
51.
Carlino D. Leone E. Di Cola F. Baj G. Marin R. Dinelli G. (2011 ). Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia. J. Psychiatr. Res. 45 273–279.
Not in our library10.1016/j.jpsychires.2010.06.012 (opens in a new tab)
52.
Cirulli F. Berry A. Chiarotti F. Alleva E. (2004 ). Intrahippocampal administration of BDNF in adult rats affects short-term behavioral plasticity in the Morris water maze and performance in the elevated plus-maze. Hippocampus 14 802–807.
Not in our library10.1002/hipo.10220 (opens in a new tab)
53.
Clark P. J. Brzezinska W. J. Thomas M. W. Ryzhenko N. A. Toshkov S. A. Rhodes J. S. (2008 ). Intact neurogenesis is required for benefits of exercise on spatial memory but not motor performance or contextual fear conditioning in C57BL/6J mice. Neuroscience 155 1048–1058.
Not in our library10.1016/j.neuroscience.2008.06.051 (opens in a new tab)
54.
Colcombe S. Kramer A. F. (2003 ). Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol. Sci. 14 125–130.
Not in our library10.1111/1467-9280.t01-1-01430 (opens in a new tab)
55.
Combarros O. Infante J. Llorca J. Berciano J. (2004 ). Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 18 55–58.
Not in our library10.1159/000077736 (opens in a new tab)
56.
Cotman C. W. Berchtold N. C. (2002 ). Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 25 295–301.
Not in our library10.1016/s0166-2236(02)02143-4 (opens in a new tab)
57.
Cotman C. W. Berchtold N. C. (2007 ). Physical activity and the maintenance of cognition: learning from animal models. Alzheimers Dement. 3 S30–S37.
Not in our library10.1016/j.jalz.2007.01.013 (opens in a new tab)
58.
Counts S. E. Mufson E. J. (2010 ). Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J. Neurochem. 113 649–660.
Not in our library10.1111/j.1471-4159.2010.06622.x (opens in a new tab)
59.
Cracchiolo J. R. Mori T. Nazian S. J. Tan J. Potter H. Arendash G. W. (2007 ). Enhanced cognitive activity–over and above social or physical activity–is required to protect Alzheimer’s mice against cognitive impairment, reduce abeta deposition, and increase synaptic immunoreactivity. Neurobiol. Learn. Mem. 88 277–294.
Not in our library10.1016/j.nlm.2007.07.007 (opens in a new tab)
60.
Chan C. B. Ye K. (2017 ). Sex differences in brain-derived neurotrophic factor signaling and functions. J. Neurosci. Res. 95 328–335.
Not in our library10.1002/jnr.23863 (opens in a new tab)
61.
Chang Y. H. Wang T. Y. Lee S. Y. Chen S. L. Huang C. C. Chen P. S. (2018 ). Memory impairment and plasma BDNF correlates of the BDNF Val66Met polymorphism in patients with bipolar II disorder. Front. Genet. 9:583.
Not in our library10.3389/fgene.2018.00583 (opens in a new tab)
62.
Chapman T. R. Barrientos R. M. Ahrendsen J. T. Hoover J. M. Maier S. F. Patterson S. L. (2012 ). Aging and infection reduce expression of specific brain-derived neurotrophic factor mRNAs in hippocampus. Neurobiol. Aging 33 832.e1–832.e14.
Not in our library10.1016/j.neurobiolaging.2011.07.015 (opens in a new tab)
63.
Charlton R. A. Barrick T. R. Markus H. S. Morris R. G. (2010 ). The relationship between episodic long-term memory and white matter integrity in normal aging. Neuropsychologia 48 114–122.
Not in our library10.1016/j.neuropsychologia.2009.08.018 (opens in a new tab)
64.
Chen W. G. West A. E. Tao X. Corfas G. Szentirmay M. N. Sawadogo M. (2003 ). Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. J. Neurosci. 23 2572–2581.
Not in our library10.1523/jneurosci.23-07-02572.2003 (opens in a new tab)
65.
Cheng B. Mattson M. P. (1994 ). NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640 56–67.
Not in our library10.1016/0006-8993(94)91857-0 (opens in a new tab)
66.
Churchill J. D. Galvez R. Colcombe S. Swain R. A. Kramer A. F. Greenough W. T. (2002 ). Exercise, experience and the aging brain. Neurobiol. Aging 23 941–955.
Not in our library10.1016/s0197-4580(02)00028-3 (opens in a new tab)
67.
Danckert S. L. Craik F. I. (2013 ). Does aging affect recall more than recognition memory? Psychol. Aging 28 902–909.
Not in our library10.1037/a0033263 (opens in a new tab)
68.
Dempster E. Toulopoulou T. Mcdonald C. Bramon E. Walshe M. Filbey F. (2005 ). Association between BDNF val66 met genotype and episodic memory. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B 73–75.
Not in our library10.1002/ajmg.b.30150 (opens in a new tab)
69.
Deng P. Anderson J. D. Yu A. S. Annett G. Fink K. D. Nolta J. A. (2016 ). Engineered BDNF producing cells as a potential treatment for neurologic disease. Expert Opin. Biol. Ther. 16 1025–1033.
Not in our library10.1080/14712598.2016.1183641 (opens in a new tab)
70.
Dennis N. A. Cabeza R. Need A. C. Waters-Metenier S. Goldstein D. B. Labar K. S. (2011 ). Brain-derived neurotrophic factor val66met polymorphism and hippocampal activation during episodic encoding and retrieval tasks. Hippocampus 21 980–989.
Not in our library10.1002/hipo.20809 (opens in a new tab)
71.
Devi L. Ohno M. (2012 ). 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer’s disease. Neuropsychopharmacology 37 434–444.
Not in our library10.1038/npp.2011.191 (opens in a new tab)
72.
Dey N. D. Bombard M. C. Roland B. P. Davidson S. Lu M. Rossignol J. (2010 ). Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington’s disease. Behav. Brain Res. 214 193–200.
Not in our library10.1016/j.bbr.2010.05.023 (opens in a new tab)
73.
Di Lazzaro V. Profice P. Pilato F. Dileone M. Florio L. Tonali P. A. (2007 ). BDNF plasma levels in acute stroke. Neurosci. Lett. 422 128–130.
Not in our library10.1016/j.neulet.2007.06.001 (opens in a new tab)
74.
Dias V. V. Brissos S. Frey B. N. Andreazza A. C. Cardoso C. Kapczinski F. (2009 ). Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord. 11 663–671.
Not in our library10.1111/j.1399-5618.2009.00733.x (opens in a new tab)
75.
Dietrich M. O. Andrews Z. B. Horvath T. L. (2008 ). Exercise-induced synaptogenesis in the hippocampus is dependent on UCP2-regulated mitochondrial adaptation. J. Neurosci. 28 10766–10771.
Not in our library10.1523/jneurosci.2744-08.2008 (opens in a new tab)
76.
Ding Q. Vaynman S. Akhavan M. Ying Z. Gomez-Pinilla F. (2006 ). Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience 140 823–833.
Not in our library10.1016/j.neuroscience.2006.02.084 (opens in a new tab)
77.
Dodds C. M. Henson R. N. Miller S. R. Nathan P. J. (2013 ). Overestimation of the effects of the BDNF val66met polymorphism on episodic memory-related hippocampal function: a critique of a recent meta-analysis. Neurosci. Biobehav. Rev. 37 739–741.
Not in our library10.1016/j.neubiorev.2013.01.019 (opens in a new tab)
78.
Drapeau E. Mayo W. Aurousseau C. Le Moal M. Piazza P. V. Abrous D. N. (2003 ). Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc. Natl. Acad. Sci. U.S.A. 100 14385–14390.
Not in our library10.1073/pnas.2334169100 (opens in a new tab)
79.
Drapeau E. Nora Abrous D. (2008 ). Stem cell review series: role of neurogenesis in age-related memory disorders. Aging Cell 7 569–589.
Not in our library10.1111/j.1474-9726.2008.00369.x (opens in a new tab)
80.
Driscoll I. Davatzikos C. An Y. Wu X. Shen D. Kraut M. (2009 ). Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 72 1906–1913.
Not in our library10.1212/wnl.0b013e3181a82634 (opens in a new tab)
81.
Driscoll I. Hamilton D. A. Petropoulos H. Yeo R. A. Brooks W. M. Baumgartner R. N. (2003 ). The aging hippocampus: cognitive, biochemical and structural findings. Cereb. Cortex 13 1344–1351.
Not in our library10.1093/cercor/bhg081 (opens in a new tab)
82.
Driscoll I. Martin B. An Y. Maudsley S. Ferrucci L. Mattson M. P. (2012 ). Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults. PLoS One 7:e35217.
Not in our library10.1371/journal.pone.0035217 (opens in a new tab)
83.
Duman R. S. Monteggia L. M. (2006 ). A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59 1116–1127.
Not in our library10.1016/j.biopsych.2006.02.013 (opens in a new tab)
84.
Durany N. Michel T. Kurt J. Cruz-Sanchez F. F. Cervos-Navarro J. Riederer P. (2000 ). Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer’s disease brains. Int. J. Dev. Neurosci. 18 807–813.
Not in our library10.1016/s0736-5748(00)00046-0 (opens in a new tab)
85.
Duzel E. Van Praag H. Sendtner M. (2016 ). Can physical exercise in old age improve memory and hippocampal function? Brain 139 662–673.
Not in our library10.1093/brain/awv407 (opens in a new tab)
86.
Dwivedi Y. Rizavi H. S. Conley R. R. Roberts R. C. Tamminga C. A. Pandey G. N. (2003 ). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 60 804–815.
Not in our library10.1001/archpsyc.60.8.804 (opens in a new tab)
87.
Eadie B. D. Redila V. A. Christie B. R. (2005 ). Voluntary exercise alters the cytoarchitecture of the adult dentate gyrus by increasing cellular proliferation, dendritic complexity, and spine density. J. Comp. Neurol. 486 39–47.
Not in our library10.1002/cne.20493 (opens in a new tab)
88.
Egan M. F. Kojima M. Callicott J. H. Goldberg T. E. Kolachana B. S. Bertolino A. (2003 ). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 257–269.
Not in our library10.1016/s0092-8674(03)00035-7 (opens in a new tab)
89.
Einoch R. Weinreb O. Mandiuk N. Youdim M. B. H. Bilker W. Silver H. (2017 ). The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia. Eur. Neuropsychopharmacol. 27 470–483.
Not in our library10.1016/j.euroneuro.2017.03.005 (opens in a new tab)
90.
Elliott E. Atlas R. Lange A. Ginzburg I. (2005 ). Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism. Eur. J. Neurosci. 22 1081–1089.
Not in our library10.1111/j.1460-9568.2005.04290.x (opens in a new tab)
91.
Erickson C. A. Barnes C. A. (2003 ). The neurobiology of memory changes in normal aging. Exp. Gerontol. 38 61–69.
Not in our library10.1016/s0531-5565(02)00160-2 (opens in a new tab)
92.
Erickson K. I. Kim J. S. Suever B. L. Voss M. W. Francis B. M. Kramer A. F. (2008 ). Genetic contributions to age-related decline in executive function: a 10-year longitudinal study of COMT and BDNF polymorphisms. Front. Hum. Neurosci. 2:11.
Not in our library10.3389/neuro.09.011.2008 (opens in a new tab)
93.
Erickson K. I. Miller D. L. Roecklein K. A. (2012 ). The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist 18 82–97.
Not in our library10.1177/1073858410397054 (opens in a new tab)
94.
Erickson K. I. Prakash R. S. Voss M. W. Chaddock L. Heo S. Mclaren M. (2010 ). Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J. Neurosci. 30 5368–5375.
Not in our library10.1523/jneurosci.6251-09.2010 (opens in a new tab)
95.
Erickson K. I. Voss M. W. Prakash R. S. Basak C. Szabo A. Chaddock L. (2011 ). Exercise training increases size of hippocampus and improves memory. Proc. Natl. Acad. Sci. U.S.A. 108 3017–3022.
Not in our library10.1073/pnas.1015950108 (opens in a new tab)
96.
Ernfors P. Ibanez C. F. Ebendal T. Olson L. Persson H. (1990 ). Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc. Natl. Acad. Sci. U.S.A. 87 5454–5458.
Not in our library10.1073/pnas.87.14.5454 (opens in a new tab)
97.
Fahnestock M. (2011 ). Brain-derived neurotrophic factor: the link between amyloid-β and memory loss. Future Neurol. 6 627–639.
Not in our library10.2217/fnl.11.44 (opens in a new tab)
98.
Fahnestock M. Marchese M. Head E. Pop V. Michalski B. Milgram W. N. (2012 ). BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog. Neurobiol. Aging 33 546–554.
Not in our library10.1016/j.neurobiolaging.2010.03.019 (opens in a new tab)
99.
Fernandes B. S. Steiner J. Berk M. Molendijk M. L. Gonzalez-Pinto A. Turck C. W. (2015 ). Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Mol. Psychiatry 20 1108–1119.
Not in our library10.1038/mp.2014.117 (opens in a new tab)
100.
Ferris L. T. Williams J. S. Shen C. L. (2007 ). The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med. Sci. Sports Exerc. 39 728–734.
Not in our library10.1249/mss.0b013e31802f04c7 (opens in a new tab)
101.
Fink K. D. Deng P. Torrest A. Stewart H. Pollock K. Gruenloh W. (2015 ). Developing stem cell therapies for juvenile and adult-onset Huntington’s disease. Regen. Med. 10 623–646.
Not in our library10.2217/rme.15.25 (opens in a new tab)
102.
Finkel D. Reynolds C. A. Mcardle J. J. Pedersen N. L. (2005 ). The longitudinal relationship between processing speed and cognitive ability: genetic and environmental influences. Behav. Genet. 35 535–549.
Not in our library10.1007/s10519-005-3281-5 (opens in a new tab)
103.
Fischer W. Sirevaag A. Wiegand S. J. Lindsay R. M. Bjorklund A. (1994 ). Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 91 8607–8611.
Not in our library10.1073/pnas.91.18.8607 (opens in a new tab)
104.
Fisher M. Mellon S. H. Wolkowitz O. Vinogradov S. (2016 ). Neuroscience-informed auditory training in schizophrenia: a final report of the effects on cognition and serum brain-derived neurotrophic factor. Schizophr. Res. Cogn. 3 1–7.
Not in our library10.1016/j.scog.2015.10.006 (opens in a new tab)
105.
Flicker C. Ferris S. H. Reisberg B. (1991 ). Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41 1006–1009.
Not in our library10.1212/wnl.41.7.1006 (opens in a new tab)
106.
Forlenza O. V. Diniz B. S. Teixeira A. L. Ojopi E. B. Talib L. L. Mendonca V. A. (2010 ). Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J. Biol. Psychiatry 11 774–780.
Not in our library10.3109/15622971003797241 (opens in a new tab)
107.
Francis B. M. Yang J. Hajderi E. Brown M. E. Michalski B. Mclaurin J. (2012 ). Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer’s disease. Neuropsychopharmacology 37 1934–1944.
Not in our library10.1038/npp.2012.40 (opens in a new tab)
108.
Frick K. M. Benoit J. D. (2010 ). Use it or lose it: environmental enrichment as a means to promote successful cognitive aging. ScientificWorldJournal 10 1129–1141.
Not in our library10.1100/tsw.2010.111 (opens in a new tab)
109.
Friedland R. P. Fritsch T. Smyth K. A. Koss E. Lerner A. J. Chen C. H. (2001 ). Patients with Alzheimer’s disease have reduced activities in midlife compared with healthy control-group members. Proc. Natl. Acad. Sci. U.S.A. 98 3440–3445.
Not in our library10.1073/pnas.061002998 (opens in a new tab)
110.
Friedman W. J. (2010 ). Proneurotrophins, seizures, and neuronal apoptosis. Neuroscientist 16 244–252.
Not in our library10.1177/1073858409349903 (opens in a new tab)
111.
Fukumoto N. Fujii T. Combarros O. Kamboh M. I. Tsai S. J. Matsushita S. (2010 ). Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer’s disease: new data and meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B 235–242.
Not in our library10.1002/ajmg.b.30986 (opens in a new tab)
112.
Fumagalli F. Racagni G. Riva M. A. (2006 ). The expanding role of BDNF: a therapeutic target for Alzheimer’s disease? Pharmacogenomics J. 6 8–15.
Not in our library10.1038/sj.tpj.6500337 (opens in a new tab)
113.
Gajewski P. D. Hengstler J. G. Golka K. Falkenstein M. Beste C. (2012 ). The Met-genotype of the BDNF Val66Met polymorphism is associated with reduced stroop interference in elderly. Neuropsychologia 50 3554–3563.
Not in our library10.1016/j.neuropsychologia.2012.09.042 (opens in a new tab)
114.
Immediate Early Genes, Memory and Psychiatric Disorders: Focus on c-Fos, Egr1 and Arc · 2018
No notice
115.
Gamiz F. Gallo M. (2012 ). Spontaneous object recognition memory in aged rats: complexity versus similarity. Learn. Mem. 19 444–448.
Not in our library10.1101/lm.027003.112 (opens in a new tab)
116.
Garcia-Mesa Y. Pareja-Galeano H. Bonet-Costa V. Revilla S. Gomez-Cabrera M. C. Gambini J. (2014 ). Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms. Psychoneuroendocrinology 45 154–166.
Not in our library10.1016/j.psyneuen.2014.03.021 (opens in a new tab)
117.
Garcia R. (2002 ). Stress, synaptic plasticity, and psychopathology. Rev. Neurosci. 13 195–208.
Not in our library10.1515/revneuro.2002.13.3.195 (opens in a new tab)
118.
Garza A. A. Ha T. G. Garcia C. Chen M. J. Russo-Neustadt A. A. (2004 ). Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacol. Biochem. Behav. 77 209–220.
Not in our library10.1016/j.pbb.2003.10.020 (opens in a new tab)
119.
Gillen J. B. Gibala M. J. (2014 ). Is high-intensity interval training a time-efficient exercise strategy to improve health and fitness? Appl. Physiol. Nutr. Metab. 39 409–412.
Not in our library10.1139/apnm-2013-0187 (opens in a new tab)
120.
Giuffrida M. L. Caraci F. Pignataro B. Cataldo S. De Bona P. Bruno V. (2009 ). Beta-amyloid monomers are neuroprotective. J. Neurosci. 29 10582–10587.
Not in our library10.1523/jneurosci.1736-09.2009 (opens in a new tab)
121.
Giuffrida M. L. Copani A. Rizzarelli E. (2018 ). A promising connection between BDNF and Alzheimer’s disease. Aging 10 1791–1792.
Not in our library10.18632/aging.101518 (opens in a new tab)
122.
Glasky A. J. Melchior C. L. Pirzadeh B. Heydari N. Ritzmann R. F. (1994 ). Effect of AIT-082, a purine analog, on working memory in normal and aged mice. Pharmacol. Biochem. Behav. 47 325–329.
Not in our library10.1016/0091-3057(94)90017-5 (opens in a new tab)
123.
Goldberg T. E. Iudicello J. Russo C. Elvevag B. Straub R. Egan M. F. (2008 ). BDNF Val66Met polymorphism significantly affects d’ in verbal recognition memory at short and long delays. Biol. Psychol. 77 20–24.
Not in our library10.1016/j.biopsycho.2007.08.009 (opens in a new tab)
124.
Gooney M. Messaoudi E. Maher F. O. Bramham C. R. Lynch M. A. (2004 ). BDNF-induced LTP in dentate gyrus is impaired with age: analysis of changes in cell signaling events. Neurobiol. Aging 25 1323–1331.
Not in our library10.1016/j.neurobiolaging.2004.01.003 (opens in a new tab)
125.
Granger R. Deadwyler S. Davis M. Moskovitz B. Kessler M. Rogers G. (1996 ). Facilitation of glutamate receptors reverses an age-associated memory impairment in rats. Synapse 22 332–337.
Not in our library10.1002/(sici)1098-2396(199604)22:4<332::aid-syn4>3.0.co;2-c (opens in a new tab)
126.
Green C. S. Bavelier D. (2008 ). Exercising your brain: a review of human brain plasticity and training-induced learning. Psychol. Aging 23 692–701.
Not in our library10.1037/a0014345 (opens in a new tab)
127.
Greene E. Naranjo J. N. (1987 ). Degeneration of hippocampal fibers and spatial memory deficit in the aged rat. Neurobiol. Aging 8 35–43.
Not in our library10.1016/0197-4580(87)90055-8 (opens in a new tab)
128.
Greenough W. T. Wood W. E. Madden T. C. (1972 ). Possible memory storage differences among mice reared in environments varying in complexity. Behav. Biol. 7 717–722.
Not in our library10.1016/s0091-6773(72)80078-6 (opens in a new tab)
129.
Gregory S. M. Parker B. Thompson P. D. (2012 ). Physical activity, cognitive function, and brain health: what is the role of exercise training in the prevention of dementia? Brain Sci. 2 684–708.
Not in our library10.3390/brainsci2040684 (opens in a new tab)
130.
Griesbach G. S. Hovda D. A. Molteni R. Wu A. Gomez-Pinilla F. (2004 ). Voluntary exercise following traumatic brain injury: brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience 125 129–139.
Not in our library10.1016/j.neuroscience.2004.01.030 (opens in a new tab)
131.
Guimond S. Beland S. Lepage M. (2018 ). Strategy for semantic association memory (SESAME) training: effects on brain functioning in schizophrenia. Psychiatry Res. Neuroimaging 271 50–58.
Not in our library10.1016/j.pscychresns.2017.10.010 (opens in a new tab)
132.
Haapasalo A. Sipola I. Larsson K. Akerman K. E. Stoilov P. Stamm S. (2002 ). Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRKB isoforms. J. Biol. Chem. 277 43160–43167.
Not in our library10.1074/jbc.m205202200 (opens in a new tab)
133.
Hall C. B. Lipton R. B. Sliwinski M. Katz M. J. Derby C. A. Verghese J. (2009 ). Cognitive activities delay onset of memory decline in persons who develop dementia. Neurology 73 356–361.
Not in our library10.1212/wnl.0b013e3181b04ae3 (opens in a new tab)
134.
Hansell N. K. James M. R. Duffy D. L. Birley A. J. Luciano M. Geffen G. M. (2007 ). Effect of the BDNF V166M polymorphism on working memory in healthy adolescents. Genes Brain Behav. 6 260–268.
Not in our library10.1111/j.1601-183x.2006.00254.x (opens in a new tab)
135.
Hariri A. R. Goldberg T. E. Mattay V. S. Kolachana B. S. Callicott J. H. Egan M. F. (2003 ). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23 6690–6694.
Not in our library10.1523/jneurosci.23-17-06690.2003 (opens in a new tab)
136.
Harris S. E. Deary I. J. (2011 ). The genetics of cognitive ability and cognitive ageing in healthy older people. Trends Cogn. Sci. 15 388–394.
Not in our library10.1016/j.tics.2011.07.004 (opens in a new tab)
137.
Harris S. E. Fox H. Wright A. F. Hayward C. Starr J. M. Whalley L. J. (2006 ). The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol. Psychiatry 11 505–513.
Not in our library10.1038/sj.mp.4001799 (opens in a new tab)
138.
Harrisberger F. Spalek K. Smieskova R. Schmidt A. Coynel D. Milnik A. (2014 ). The association of the BDNF Val66Met polymorphism and the hippocampal volumes in healthy humans: a joint meta-analysis of published and new data. Neurosci. Biobehav. Rev. 42 267–278.
Not in our library10.1016/j.neubiorev.2014.03.011 (opens in a new tab)
139.
The Emerging Neurobiology of Bipolar Disorder · 2018
No notice
140.
Haworth C. M. Wright M. J. Luciano M. Martin N. G. De Geus E. J. Van Beijsterveldt C. E. (2010 ). The heritability of general cognitive ability increases linearly from childhood to young adulthood. Mol. Psychiatry 15 1112–1120.
Not in our library10.1038/mp.2009.55 (opens in a new tab)
141.
Hayashi M. Mistunaga F. Ohira K. Shimizu K. (2001 ). Changes in BDNF-immunoreactive structures in the hippocampal formation of the aged macaque monkey. Brain Res. 918 191–196.
Not in our library10.1016/s0006-8993(01)03002-5 (opens in a new tab)
142.
Hayashi M. Ueyama T. Nemoto K. Tamaki T. Senba E. (2000 ). Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J. Neurotrauma 17 203–218.
Not in our library10.1089/neu.2000.17.203 (opens in a new tab)
143.
Hayes V. Y. Towner M. D. Isackson P. J. (1997 ). Organization, sequence and functional analysis of a mouse BDNF promoter. Brain Res. Mol. Brain Res. 45 189–198.
Not in our library10.1016/s0169-328x(96)00254-9 (opens in a new tab)
144.
Heffernan J. M. Eastwood S. L. Nagy Z. Sanders M. W. Mcdonald B. Harrison P. J. (1998 ). Temporal cortex synaptophysin mRNA is reduced in Alzheimer’s disease and is negatively correlated with the severity of dementia. Exp. Neurol. 150 235–239.
Not in our library10.1006/exnr.1997.6772 (opens in a new tab)
145.
Heitz U. Papmeyer M. Studerus E. Egloff L. Ittig S. Andreou C. (2018 ). Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients. World J. Biol. Psychiatry 25 1–10.
Not in our library10.1080/15622975.2018.1462532 (opens in a new tab)
146.
Heldt S. A. Stanek L. Chhatwal J. P. Ressler K. J. (2007 ). Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol. Psychiatry 12 656–670.
Not in our library10.1038/sj.mp.4001957 (opens in a new tab)
147.
Hillman C. H. Erickson K. I. Kramer A. F. (2008 ). Be smart, exercise your heart: exercise effects on brain and cognition. Nat. Rev. Neurosci. 9 58–65.
Not in our library10.1038/nrn2298 (opens in a new tab)
148.
Hock C. Heese K. Hulette C. Rosenberg C. Otten U. (2000 ). Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch. Neurol. 57 846–851.
Not in our library10.1001/archneur.57.6.846 (opens in a new tab)
149.
Hofer M. Pagliusi S. R. Hohn A. Leibrock J. Barde Y. A. (1990 ). Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9 2459–2464.
Not in our library10.1002/j.1460-2075.1990.tb07423.x (opens in a new tab)
150.
Hoffman A. N. Krigbaum A. Ortiz J. B. Mika A. Hutchinson K. M. Bimonte-Nelson H. A. (2011 ). Recovery after chronic stress within spatial reference and working memory domains: correspondence with hippocampal morphology. Eur. J. Neurosci. 34 1023–1030.
Not in our library10.1111/j.1460-9568.2011.07820.x (opens in a new tab)
151.
Hoffmann K. Sobol N. A. Frederiksen K. S. Beyer N. Vogel A. Vestergaard K. (2016 ). Moderate-to-high intensity physical exercise in patients with Alzheimer’s disease: a randomized controlled trial. J. Alzheimers Dis. 50 443–453.
Not in our library10.3233/jad-150817 (opens in a new tab)
152.
Holden H. M. Gilbert P. E. (2012 ). Less efficient pattern separation may contribute to age-related spatial memory deficits. Front. Aging Neurosci. 4:9.
Not in our library10.3389/fnagi.2012.00009 (opens in a new tab)
153.
Hopkins M. E. Bucci D. J. (2010 ). BDNF expression in perirhinal cortex is associated with exercise-induced improvement in object recognition memory. Neurobiol. Learn. Mem. 94 278–284.
Not in our library10.1016/j.nlm.2010.06.006 (opens in a new tab)
154.
Hopkins M. E. Nitecki R. Bucci D. J. (2011 ). Physical exercise during adolescence versus adulthood: differential effects on object recognition memory and brain-derived neurotrophic factor levels. Neuroscience 194 84–94.
Not in our library10.1016/j.neuroscience.2011.07.071 (opens in a new tab)
155.
Horch H. W. Katz L. C. (2002 ). BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat. Neurosci. 5 1177–1184.
Not in our library10.1038/nn927 (opens in a new tab)
156.
Hori H. Yoshimura R. Katsuki A. Atake K. Igata R. Konishi Y. (2017 ). Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy. World J. Biol. Psychiatry 18 401–408.
Not in our library10.1080/15622975.2016.1212172 (opens in a new tab)
157.
Horn J. L. Cattell R. B. (1966 ). Age differences in primary mental ability factors. J. Gerontol. 21 210–220.
Not in our library10.1093/geronj/21.2.210 (opens in a new tab)
158.
Houlihan L. M. Harris S. E. Luciano M. Gow A. J. Starr J. M. Visscher P. M. (2009 ). Replication study of candidate genes for cognitive abilities: the Lothian Birth Cohort 1936. Genes Brain Behav. 8 238–247.
Not in our library10.1111/j.1601-183x.2008.00470.x (opens in a new tab)
159.
Hsiao Y. H. Hung H. C. Chen S. H. Gean P. W. (2014 ). Social interaction rescues memory deficit in an animal model of Alzheimer’s disease by increasing BDNF-dependent hippocampal neurogenesis. J. Neurosci. 34 16207–16219.
Not in our library10.1523/jneurosci.0747-14.2014 (opens in a new tab)
160.
Hsu C. Y. An G. Liu J. S. Xue J. J. He Y. Y. Lin T. N. (1993 ). Expression of immediate early gene and growth factor mRNAs in a focal cerebral ischemia model in the rat. Stroke 24 I78–I81.
Not in our library
161.
Huang E. J. Reichardt L. F. (2001 ). Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24 677–736.
Not in our library10.1146/annurev.neuro.24.1.677 (opens in a new tab)
162.
Hundley W. G. Kitzman D. W. Morgan T. M. Hamilton C. A. Darty S. N. Stewart K. P. (2001 ). Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J. Am. Coll. Cardiol. 38 796–802.
Not in our library10.1016/s0735-1097(01)01447-4 (opens in a new tab)
163.
Intlekofer K. A. Cotman C. W. (2013 ). Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol. Dis. 57 47–55.
Not in our library10.1016/j.nbd.2012.06.011 (opens in a new tab)
164.
Iritani S. Niizato K. Nawa H. Ikeda K. Emson P. C. (2003 ). Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 801–807.
Not in our library10.1016/s0278-5846(03)00112-x (opens in a new tab)
165.
Issa G. Wilson C. Terry A. V. Jr. Pillai A. (2010 ). An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol. Dis. 39 327–333.
Not in our library10.1016/j.nbd.2010.04.017 (opens in a new tab)
166.
Jack CR. Jr. Petersen R. C. Xu Y. O’Brien P. C. Smith G. E. Ivnik R. J. (1998 ). Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology 51 993–999.
Not in our library10.1212/wnl.51.4.993 (opens in a new tab)
167.
Jayaweera H. K. Hickie I. B. Duffy S. L. Mowszowski L. Norrie L. Lagopoulos J. (2016 ). Episodic memory in depression: the unique contribution of the anterior caudate and hippocampus. Psychol. Med. 46 2189–2199.
Not in our library10.1017/s0033291716000787 (opens in a new tab)
168.
Jiang X. Tian F. Mearow K. Okagaki P. Lipsky R. H. Marini A. M. (2005 ). The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J. Neurochem. 94 713–722.
Not in our library10.1111/j.1471-4159.2005.03200.x (opens in a new tab)
169.
Jobst K. A. Smith A. D. Szatmari M. Esiri M. M. Jaskowski A. Hindley N. (1994 ). Rapidly progressing atrophy of medial temporal lobe in Alzheimer’s disease. Lancet 343 829–830.
Not in our library10.1016/s0140-6736(94)92028-1 (opens in a new tab)
170.
Jones T. C. Jacoby L. L. (2005 ). Conjunction errors in recognition memory: modality-free errors for older adults but not for young adults. Acta Psychol. 120 55–73.
Not in our library10.1016/j.actpsy.2005.03.003 (opens in a new tab)
171.
Joyce N. Annett G. Wirthlin L. Olson S. Bauer G. Nolta J. A. (2010 ). Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen. Med. 5 933–946.
Not in our library10.2217/rme.10.72 (opens in a new tab)
172.
Kailainathan S. Piers T. M. Yi J. H. Choi S. Fahey M. S. Borger E. (2016 ). Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF). Pharmacol. Res. 104 97–107.
Not in our library10.1016/j.phrs.2015.12.008 (opens in a new tab)
173.
Kambeitz J. P. Bhattacharyya S. Kambeitz-Ilankovic L. M. Valli I. Collier D. A. Mcguire P. (2012 ). Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neurosci. Biobehav. Rev. 36 2165–2177.
Not in our library10.1016/j.neubiorev.2012.07.002 (opens in a new tab)
174.
Karnik M. S. Wang L. Barch D. M. Morris J. C. Csernansky J. G. (2010 ). BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Res. 178 425–429.
Not in our library10.1016/j.psychres.2009.09.008 (opens in a new tab)
175.
Katoh-Semba R. Asano T. Ueda H. Morishita R. Takeuchi I. K. Inaguma Y. (2002 ). Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J. 16 1328–1330.
Not in our library10.1096/fj.02-0143fje (opens in a new tab)
176.
Kauer-Sant’Anna M. Kapczinski F. Andreazza A. C. Bond D. J. Lam R. W. Young L. T. (2009 ). Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int. J. Neuropsychopharmacol. 12 447–458.
Not in our library10.1017/s1461145708009310 (opens in a new tab)
177.
Kennedy K. M. Reese E. D. Horn M. M. Sizemore A. N. Unni A. K. Meerbrey M. E. (2015 ). BDNF val66met polymorphism affects aging of multiple types of memory. Brain Res. 1612 104–117.
Not in our library10.1016/j.brainres.2014.09.044 (opens in a new tab)
178.
Kerschensteiner M. Gallmeier E. Behrens L. Leal V. V. Misgeld T. Klinkert W. E. (1999 ). Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189 865–870.
Not in our library10.1084/jem.189.5.865 (opens in a new tab)
179.
Kesslak J. P. So V. Choi J. Cotman C. W. Gomez-Pinilla F. (1998 ). Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? Behav. Neurosci. 112 1012–1019.
Not in our library10.1037//0735-7044.112.4.1012 (opens in a new tab)
180.
Kidd S. Spaeth E. Dembinski J. L. Dietrich M. Watson K. Klopp A. (2009 ). Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27 2614–2623.
Not in our library10.1002/stem.187 (opens in a new tab)
181.
Kim D. M. Leem Y. H. (2016 ). Chronic stress-induced memory deficits are reversed by regular exercise via AMPK-mediated BDNF induction. Neuroscience 324 271–285.
Not in our library10.1016/j.neuroscience.2016.03.019 (opens in a new tab)
182.
Kim E. J. Pellman B. Kim J. J. (2015 ). Stress effects on the hippocampus: a critical review. Learn. Mem. 22 411–416.
Not in our library10.1101/lm.037291.114 (opens in a new tab)
183.
Kim H. S. Moore M. T. (2019 ). Symptoms of depression and the discrepancy between implicit and explicit self-esteem. J. Behav. Ther. Exp. Psychiatry 63 1–5.
Not in our library10.1016/j.jbtep.2018.12.001 (opens in a new tab)
184.
Kim J. J. Yoon K. S. (1998 ). Stress: metaplastic effects in the hippocampus. Trends Neurosci. 21 505–509.
Not in our library10.1016/s0166-2236(98)01322-8 (opens in a new tab)
185.
Kim S. Jeneson A. Van Der Horst A. S. Frascino J. C. Hopkins R. O. Squire L. R. (2011 ). Memory, visual discrimination performance, and the human hippocampus. J. Neurosci. 31 2624–2629.
Not in our library10.1523/jneurosci.5954-10.2011 (opens in a new tab)
186.
Kiprianova I. Freiman T. M. Desiderato S. Schwab S. Galmbacher R. Gillardon F. (1999 ). Brain-derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat. J. Neurosci. Res. 56 21–27.
Not in our library10.1002/(sici)1097-4547(19990401)56:1<21::aid-jnr3>3.0.co;2-q (opens in a new tab)
187.
Kleim J. A. Chan S. Pringle E. Schallert K. Procaccio V. Jimenez R. (2006 ). BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat. Neurosci. 9 735–737.
Not in our library10.1038/nn1699 (opens in a new tab)
188.
Klein A. B. Williamson R. Santini M. A. Clemmensen C. Ettrup A. Rios M. (2011 ). Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int. J. Neuropsychopharmacol. 14 347–353.
Not in our library10.1017/s1461145710000738 (opens in a new tab)
189.
Kollen M. Stephan A. Faivre-Bauman A. Loudes C. Sinet P. M. Alliot J. (2010 ). Preserved memory capacities in aged Lou/C/Jall rats. Neurobiol. Aging 31 129–142.
Not in our library10.1016/j.neurobiolaging.2008.03.010 (opens in a new tab)
190.
Kosse N. M. Dutmer A. L. Dasenbrock L. Bauer J. M. Lamoth C. J. (2013 ). Effectiveness and feasibility of early physical rehabilitation programs for geriatric hospitalized patients: a systematic review. BMC Geriatr. 13:107.
Not in our library10.1186/1471-2318-13-107 (opens in a new tab)
191.
Kremen W. S. Jacobsen K. C. Xian H. Eisen S. A. Eaves L. J. Tsuang M. T. (2007 ). Genetics of verbal working memory processes: a twin study of middle-aged men. Neuropsychology 21 569–580.
Not in our library10.1037/0894-4105.21.5.569 (opens in a new tab)
192.
Kronenberg G. Bick-Sander A. Bunk E. Wolf C. Ehninger D. Kempermann G. (2006 ). Physical exercise prevents age-related decline in precursor cell activity in the mouse dentate gyrus. Neurobiol. Aging 27 1505–1513.
Not in our library10.1016/j.neurobiolaging.2005.09.016 (opens in a new tab)
193.
Kumar A. (2011 ). Long-term potentiation at CA3-CA1 hippocampal synapses with special emphasis on aging, disease, and stress. Front. Aging Neurosci. 3:7.
Not in our library10.3389/fnagi.2011.00007 (opens in a new tab)
194.
Kunugi H. Ueki A. Otsuka M. Isse K. Hirasawa H. Kato N. (2001 ). A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer’s disease. Mol. Psychiatry 6 83–86.
Not in our library10.1038/sj.mp.4000792 (opens in a new tab)
195.
Kwon D. H. Kim B. S. Chang H. Kim Y. I. Jo S. A. Leem Y. H. (2013 ). Exercise ameliorates cognition impairment due to restraint stress-induced oxidative insult and reduced BDNF level. Biochem. Biophys. Res. Commun. 434 245–251.
Not in our library10.1016/j.bbrc.2013.02.111 (opens in a new tab)
196.
Laing K. R. Mitchell D. Wersching H. Czira M. E. Berger K. Baune B. T. (2012 ). Brain-derived neurotrophic factor (BDNF) gene: a gender-specific role in cognitive function during normal cognitive aging of the MEMO-Study? Age 34 1011–1022.
Not in our library10.1007/s11357-011-9275-8 (opens in a new tab)
197.
Lambert J. C. Grenier-Boley B. Harold D. Zelenika D. Chouraki V. Kamatani Y. (2013 ). Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer’s disease. Mol. Psychiatry 18 461–470.
Not in our library10.1038/mp.2012.14 (opens in a new tab)
198.
Lapchak P. A. Araujo D. M. Beck K. D. Finch C. E. Johnson S. A. Hefti F. (1993 ). BDNF and trkB mRNA expression in the hippocampal formation of aging rats. Neurobiol. Aging 14 121–126.
Not in our library10.1016/0197-4580(93)90087-r (opens in a new tab)
199.
Larsen M. H. Mikkelsen J. D. Hay-Schmidt A. Sandi C. (2010 ). Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J. Psychiatr. Res. 44 808–816.
Not in our library10.1016/j.jpsychires.2010.01.005 (opens in a new tab)
200.
Larson E. B. Wang L. Bowen J. D. Mccormick W. C. Teri L. Crane P. (2006 ). Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144 73–81.
Not in our library10.7326/0003-4819-144-2-200601170-00004 (opens in a new tab)
201.
Laske C. Stellos K. Hoffmann N. Stransky E. Straten G. Eschweiler G. W. (2011 ). Higher BDNF serum levels predict slower cognitive decline in Alzheimer’s disease patients. Int. J. Neuropsychopharmacol. 14 399–404.
Not in our library10.1017/s1461145710001008 (opens in a new tab)
202.
Laske C. Stransky E. Leyhe T. Eschweiler G. W. Wittorf A. Richartz E. (2006 ). Stage-dependent BDNF serum concentrations in Alzheimer’s disease. J. Neural Transm. 113 1217–1224.
Not in our library10.1007/s00702-005-0397-y (opens in a new tab)
203.
Lauterborn J. C. Poulsen F. R. Stinis C. T. Isackson P. J. Gall C. M. (1998 ). Transcript-specific effects of adrenalectomy on seizure-induced BDNF expression in rat hippocampus. Brain Res. Mol. Brain Res. 55 81–91.
Not in our library10.1016/s0169-328x(97)00368-9 (opens in a new tab)
204.
Lauterborn J. C. Truong G. S. Baudry M. Bi X. Lynch G. Gall C. M. (2003 ). Chronic elevation of brain-derived neurotrophic factor by ampakines. J. Pharmacol. Exp. Ther. 307 297–305.
Not in our library10.1124/jpet.103.053694 (opens in a new tab)
205.
Lee J. M. Ross E. R. Gower A. Paris J. M. Martensson R. Lorens S. A. (1994 ). Spatial learning deficits in the aged rat: neuroanatomical and neurochemical correlates. Brain Res. Bull. 33 489–500.
Not in our library10.1016/0361-9230(94)90073-6 (opens in a new tab)
206.
Lee R. Kermani P. Teng K. K. Hempstead B. L. (2001 ). Regulation of cell survival by secreted proneurotrophins. Science 294 1945–1948.
Not in our library10.1126/science.1065057 (opens in a new tab)
207.
Lee S. H. Kim Y. J. Lee K. M. Ryu S. Yoon B. W. (2007 ). Ischemic preconditioning enhances neurogenesis in the subventricular zone. Neuroscience 146 1020–1031.
Not in our library10.1016/j.neuroscience.2007.02.058 (opens in a new tab)
208.
Lessmann V. Gottmann K. Malcangio M. (2003 ). Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 69 341–374.
Not in our library10.1016/s0301-0082(03)00019-4 (opens in a new tab)
209.
Lessov-Schlaggar C. N. Swan G. E. Reed T. Wolf P. A. Carmelli D. (2007 ). Longitudinal genetic analysis of executive function in elderly men. Neurobiol. Aging 28 1759–1768.
Not in our library10.1016/j.neurobiolaging.2006.07.018 (opens in a new tab)
210.
Leyhe T. Stransky E. Eschweiler G. W. Buchkremer G. Laske C. (2008 ). Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease. Eur. Arch. Psychiatry Clin. Neurosci. 258 124–128.
Not in our library10.1007/s00406-007-0764-9 (opens in a new tab)
211.
Li Y. Rowland C. Tacey K. Catanese J. Sninsky J. Hardy J. (2005 ). The BDNF Val66Met polymorphism is not associated with late onset Alzheimer’s disease in three case-control samples. Mol. Psychiatry 10 809–810.
Not in our library10.1038/sj.mp.4001702 (opens in a new tab)
212.
Light L. L. (1991 ). Memory and aging: four hypotheses in search of data. Annu. Rev. Psychol. 42 333–376.
Not in our library10.1146/annurev.ps.42.020191.002001 (opens in a new tab)
213.
Lim Y. Y. Hassenstab J. Cruchaga C. Goate A. Fagan A. M. Benzinger T. L. (2016 ). BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease. Brain 139 2766–2777.
Not in our library10.1093/aww201 (opens in a new tab)
214.
Lim Y. Y. Villemagne V. L. Laws S. M. Ames D. Pietrzak R. H. Ellis K. A. (2013 ). BDNF Val66Met, Abeta amyloid, and cognitive decline in preclinical Alzheimer’s disease. Neurobiol. Aging 34 2457–2464.
Not in our library10.1016/j.neurobiolaging.2013.05.006 (opens in a new tab)
215.
Lin S. Y. Wu K. Levine E. S. Mount H. T. Suen P. C. Black I. B. (1998 ). BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Brain Res. Mol. Brain Res. 55 20–27.
Not in our library10.1016/s0169-328x(97)00349-5 (opens in a new tab)
216.
Lin X. Lu D. Huang Z. Chen W. Luo X. Zhu Y. (2019 ). The associations between subjective and objective cognitive functioning across manic or hypomanic, depressed, and euthymic states in Chinese bipolar patients. J. Affect. Disord. 249 73–81.
Not in our library10.1016/j.jad.2019.02.025 (opens in a new tab)
217.
Lindenberger U. Nagel I. E. Chicherio C. Li S. C. Heekeren H. R. Backman L. (2008 ). Age-related decline in brain resources modulates genetic effects on cognitive functioning. Front. Neurosci. 2:234–244.
Not in our library10.3389/neuro.01.039.2008 (opens in a new tab)
218.
Lindvall O. Kokaia Z. Bengzon J. Elmer E. Kokaia M. (1994 ). Neurotrophins and brain insults. Trends Neurosci. 17 490–496.
Not in our library10.1016/0166-2236(94)90139-2 (opens in a new tab)
219.
Lippa C. F. Hamos J. E. Pulaski-Salo D. Degennaro L. J. Drachman D. A. (1992 ). Alzheimer’s disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol. Aging 13 405–411.
Not in our library10.1016/0197-4580(92)90115-e (opens in a new tab)
220.
Lister J. P. Barnes C. A. (2009 ). Neurobiological changes in the hippocampus during normative aging. Arch. Neurol. 66 829–833.
Not in our library10.1001/archneurol.2009.125 (opens in a new tab)
221.
Liu P. Gupta N. Jing Y. Zhang H. (2008 ). Age-related changes in polyamines in memory-associated brain structures in rats. Neuroscience 155 789–796.
Not in our library10.1016/j.neuroscience.2008.06.033 (opens in a new tab)
222.
Liu Q. R. Walther D. Drgon T. Polesskaya O. Lesnick T. G. Strain K. J. (2005 ). Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson’s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B 93–103.
Not in our library10.1002/ajmg.b.30109 (opens in a new tab)
223.
Liu X. J. Zhang L. Zhang Y. F. Xu W. Hu Y. Liu Y. (2018 ). Echogenic alteration in the raphe nuclei measured by transcranial sonography in patients with Parkinson disease and depression. Medicine 97:e13524.
Not in our library10.1097/md.0000000000013524 (opens in a new tab)
224.
Lubin F. D. Roth T. L. Sweatt J. D. (2008 ). Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J. Neurosci. 28 10576–10586.
Not in our library10.1523/jneurosci.1786-08.2008 (opens in a new tab)
225.
Lugert S. Basak O. Knuckles P. Haussler U. Fabel K. Gotz M. (2010 ). Quiescent and active hippocampal neural stem cells with distinct morphologies respond selectively to physiological and pathological stimuli and aging. Cell Stem Cell 6 445–456.
Not in our library10.1016/j.stem.2010.03.017 (opens in a new tab)
226.
Luine V. Villegas M. Martinez C. Mcewen B. S. (1994 ). Repeated stress causes reversible impairments of spatial memory performance. Brain Res. 639 167–170.
Not in our library10.1016/0006-8993(94)91778-7 (opens in a new tab)
227.
Luo C. X. Jiang J. Zhou Q. G. Zhu X. J. Wang W. Zhang Z. J. (2007 ). Voluntary exercise-induced neurogenesis in the postischemic dentate gyrus is associated with spatial memory recovery from stroke. J. Neurosci. Res. 85 1637–1646.
Not in our library10.1002/jnr.21317 (opens in a new tab)
228.
Lynch G. Rex C. S. Gall C. M. (2006 ). Synaptic plasticity in early aging. Ageing Res. Rev. 5 255–280.
Not in our library10.1016/j.arr.2006.03.008 (opens in a new tab)
229.
Ma X. C. Liu P. Zhang X. L. Jiang W. H. Jia M. Wang C. X. (2016 ). Intranasal delivery of recombinant AAV containing BDNF fused with HA2TAT: a potential promising therapy strategy for major depressive disorder. Sci. Rep. 6:22404.
Not in our library10.1038/srep22404 (opens in a new tab)
230.
Maisonpierre P. C. Le Beau M. M. Espinosa R. III Ip N. Y. Belluscio L. De La Monte S. M. (1991 ). Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10 558–568.
Not in our library10.1016/0888-7543(91)90436-i (opens in a new tab)
231.
Malkova L. Bachevalier J. Mishkin M. Saunders R. C. (2001 ). Neurotoxic lesions of perirhinal cortex impair visual recognition memory in rhesus monkeys. Neuroreport 12 1913–1917.
Not in our library10.1097/00001756-200107030-00029 (opens in a new tab)
232.
Mamounas L. A. Blue M. E. Siuciak J. A. Altar C. A. (1995 ). Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15 7929–7939.
Not in our library10.1523/jneurosci.15-12-07929.1995 (opens in a new tab)
233.
Mandelman S. D. Grigorenko E. L. (2012 ). BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association. Genes Brain Behav. 11 127–136.
Not in our library10.1111/j.1601-183x.2011.00738.x (opens in a new tab)
234.
Markowska A. L. Savonenko A. V. (2002 ). Protective effect of practice on cognition during aging: implications for predictive characteristics of performance and efficacy of practice. Neurobiol. Learn. Mem. 78 294–320.
Not in our library10.1006/nlme.2002.4064 (opens in a new tab)
235.
Marlatt M. W. Potter M. C. Lucassen P. J. Van Praag H. (2012 ). Running throughout middle-age improves memory function, hippocampal neurogenesis, and BDNF levels in female C57BL/6J mice. Dev. Neurobiol. 72 943–952.
Not in our library10.1002/dneu.22009 (opens in a new tab)
236.
Marvanova M. Lakso M. Pirhonen J. Nawa H. Wong G. Castren E. (2001 ). The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol. Cell Neurosci. 18 247–258.
Not in our library10.1006/mcne.2001.1027 (opens in a new tab)
237.
Mascetti L. Foret A. Schrouff J. Muto V. Dideberg V. Balteau E. (2013 ). Concurrent synaptic and systems memory consolidation during sleep. J. Neurosci. 33 10182–10190.
Not in our library10.1523/jneurosci.0284-13.2013 (opens in a new tab)
238.
Matrone C. Ciotti M. T. Mercanti D. Marolda R. Calissano P. (2008 ). NGF and BDNF signaling control amyloidogenic route and abeta production in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 105 13139–13144.
Not in our library10.1073/pnas.0806133105 (opens in a new tab)
239.
Matsuo K. Walss-Bass C. Nery F. G. Nicoletti M. A. Hatch J. P. Frey B. N. (2009 ). Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology 34 1904–1913.
Not in our library10.1038/npp.2009.23 (opens in a new tab)
240.
Matsushita S. Arai H. Matsui T. Yuzuriha T. Urakami K. Masaki T. (2005 ). Brain-derived neurotrophic factor gene polymorphisms and Alzheimer’s disease. J. Neural Transm. 112 703–711.
Not in our library10.1007/s00702-004-0210-3 (opens in a new tab)
241.
Mattson M. P. Duan W. Guo Z. (2003 ). Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J. Neurochem. 84 417–431.
Not in our library10.1046/j.1471-4159.2003.01586.x (opens in a new tab)
242.
Mattson M. P. Duan W. Maswood N. (2002 ). How does the brain control lifespan? Ageing Res. Rev. 1 155–165.
Not in our library10.1016/s1568-1637(01)00003-4 (opens in a new tab)
243.
Mattson M. P. Maudsley S. Martin B. (2004 ). BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 27 589–594.
Not in our library10.1016/j.tins.2004.08.001 (opens in a new tab)
244.
McAllister A. K. Katz L. C. Lo D. C. (1999 ). Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 22 295–318.
Not in our library10.1146/annurev.neuro.22.1.295 (opens in a new tab)
245.
McTighe S. M. Cowell R. A. Winters B. D. Bussey T. J. Saksida L. M. (2010 ). Paradoxical false memory for objects after brain damage. Science 330 1408–1410.
Not in our library10.1126/science.1194780 (opens in a new tab)
246.
Meisner F. Scheller C. Kneitz S. Sopper S. Neuen-Jacob E. Riederer P. (2008 ). Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33 2228–2236.
Not in our library10.1038/sj.npp.1301615 (opens in a new tab)
247.
Merkley C. M. Jian C. Mosa A. Tan Y. F. Wojtowicz J. M. (2014 ). Homeostatic regulation of adult hippocampal neurogenesis in aging rats: long-term effects of early exercise. Front. Neurosci. 8:174.
Not in our library10.3389/fnins.2014.00174 (opens in a new tab)
248.
Metsis M. Timmusk T. Arenas E. Persson H. (1993 ). Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc. Natl. Acad. Sci. U.S.A. 90 8802–8806.
Not in our library10.1073/pnas.90.19.8802 (opens in a new tab)
249.
Miller R. M. Marriott D. Trotter J. Hammond T. Lyman D. Call T. (2018 ). Running exercise mitigates the negative consequences of chronic stress on dorsal hippocampal long-term potentiation in male mice. Neurobiol. Learn. Mem. 149 28–38.
Not in our library10.1016/j.nlm.2018.01.008 (opens in a new tab)
250.
Miranda M. Kent B. A. Morici J. F. Gallo F. Weisstaub N. V. Saksida L. M. (2017 ). Molecular mechanisms in perirhinal cortex selectively necessary for discrimination of overlapping memories, but independent of memory persistence. eNeuro 4:ENEURO.0293-17.2017.
Not in our library10.1523/eneuro.0293-17.2017 (opens in a new tab)
251.
Miyajima F. Ollier W. Mayes A. Jackson A. Thacker N. Rabbitt P. (2008 ). Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav. 7 411–417.
Not in our library10.1111/j.1601-183x.2007.00363.x (opens in a new tab)
252.
Mizuno M. Yamada K. Olariu A. Nawa H. Nabeshima T. (2000 ). Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J. Neurosci. 20 7116–7121.
Not in our library10.1523/jneurosci.20-18-07116.2000 (opens in a new tab)
253.
Molendijk M. L. Bus B. A. Spinhoven P. Penninx B. W. Kenis G. Prickaerts J. (2011 ). Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol. Psychiatry 16 1088–1095.
Not in our library10.1038/mp.2010.98 (opens in a new tab)
254.
Molteni R. Barnard R. J. Ying Z. Roberts C. K. Gomez-Pinilla F. (2002a ). A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 112 803–814.
Not in our library10.1016/s0306-4522(02)00123-9 (opens in a new tab)
255.
Molteni R. Ying Z. Gomez-Pinilla F. (2002b ). Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. Eur. J. Neurosci. 16 1107–1116.
Not in our library10.1046/j.1460-9568.2002.02158.x (opens in a new tab)
256.
Montag C. Weber B. Fliessbach K. Elger C. Reuter M. (2009 ). The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol. Med. 39 1831–1839.
Not in our library10.1017/s0033291709005509 (opens in a new tab)
257.
Mora E. Portella M. J. Pinol-Ripoll G. Lopez R. Cuadras D. Forcada I. (2019 ). High BDNF serum levels are associated to good cognitive functioning in bipolar disorder. Eur. Psychiatry. 60 97–107.
Not in our library10.1016/j.eurpsy.2019.02.006 (opens in a new tab)
258.
Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1 · 2017
No notice
259.
Morris J. C. Price J. L. (2001 ). Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer’s disease. J. Mol. Neurosci. 17 101–118.
Not in our library10.1385/jmn:17:2:101 (opens in a new tab)
260.
Morrison J. H. Hof P. R. (1997 ). Life and death of neurons in the aging brain. Science 278 412–419.
Not in our library10.1126/science.278.5337.412 (opens in a new tab)
261.
Morse J. K. Wiegand S. J. Anderson K. You Y. Cai N. Carnahan J. (1993 ). Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J. Neurosci. 13 4146–4156.
Not in our library10.1523/jneurosci.13-10-04146.1993 (opens in a new tab)
262.
Moss M. B. Rosene D. L. Peters A. (1988 ). Effects of aging on visual recognition memory in the rhesus monkey. Neurobiol. Aging 9 495–502.
Not in our library10.1016/s0197-4580(88)80103-9 (opens in a new tab)
263.
Mowla S. J. Farhadi H. F. Pareek S. Atwal J. K. Morris S. J. Seidah N. G. (2001 ). Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 276 12660–12666.
Not in our library10.1074/jbc.m008104200 (opens in a new tab)
264.
Moyer J. R. Jr. Furtak S. C. Mcgann J. P. Brown T. H. (2011 ). Aging-related changes in calcium-binding proteins in rat perirhinal cortex. Neurobiol. Aging 32 1693–1706.
Not in our library10.1016/j.neurobiolaging.2009.10.001 (opens in a new tab)
265.
Evolution of Neuroplasticity in Response to Physical Activity in Old Age: The Case for Dancing · 2017
No notice
266.
Murakami S. Imbe H. Morikawa Y. Kubo C. Senba E. (2005 ). Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci. Res. 53 129–139.
Not in our library10.1016/j.neures.2005.06.008 (opens in a new tab)
267.
Murer M. G. Yan Q. Raisman-Vozari R. (2001 ). Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog. Neurobiol. 63 71–124.
Not in our library10.1016/s0301-0082(00)00014-9 (opens in a new tab)
268.
Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes · 2017
No notice
269.
Nagahara A. H. Merrill D. A. Coppola G. Tsukada S. Schroeder B. E. Shaked G. M. (2009 ). Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat. Med. 15 331–337.
Not in our library10.1038/nm.1912 (opens in a new tab)
270.
Narisawa-Saito M. Nawa H. (1996 ). Differential regulation of hippocampal neurotrophins during aging in rats. J. Neurochem. 67 1124–1131.
Not in our library10.1046/j.1471-4159.1996.67031124.x (opens in a new tab)
271.
Naveh-Benjamin M. (2000 ). Adult age differences in memory performance: tests of an associative deficit hypothesis. J. Exp. Psychol. Learn. Mem. Cogn. 26 1170–1187.
Not in our library10.1037//0278-7393.26.5.1170 (opens in a new tab)
272.
Neeper S. A. Gomez-Pinilla F. Choi J. Cotman C. W. (1996 ). Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 726 49–56.
Not in our library10.1016/0006-8993(96)00273-9 (opens in a new tab)
273.
Neves G. Cooke S. F. Bliss T. V. (2008 ). Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 9 65–75.
Not in our library10.1038/nrn2303 (opens in a new tab)
274.
Newton I. G. Forbes M. E. Legault C. Johnson J. E. Brunso-Bechtold J. K. Riddle D. R. (2005 ). Caloric restriction does not reverse aging-related changes in hippocampal BDNF. Neurobiol. Aging 26 683–688.
Not in our library10.1016/j.neurobiolaging.2004.06.005 (opens in a new tab)
275.
Ngandu T. Lehtisalo J. Solomon A. Levalahti E. Ahtiluoto S. Antikainen R. (2015 ). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385 2255–2263.
Not in our library10.1016/s0140-6736(15)60461-5 (opens in a new tab)
276.
Not only cardiovascular, but also coordinative exercise increases hippocampal volume in older adults · 2014
No notice
277.
BDNF and Schizophrenia: From Neurodevelopment to Neuronal Plasticity, Learning, and Memory · 2013
No notice
278.
Ninan I. Bath K. G. Dagar K. Perez-Castro R. Plummer M. R. Lee F. S. (2010 ). The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus. J. Neurosci. 30 8866–8870.
Not in our library10.1523/jneurosci.1405-10.2010 (opens in a new tab)
279.
Nishimura A. L. Oliveira J. R. Mitne-Neto M. Guindalini C. Nitrini R. Bahia V. S. (2004 ). Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer’s disease (LOAD) in Brazilian patients. J. Mol. Neurosci. 22 257–260.
Not in our library10.1385/jmn:22:3:257 (opens in a new tab)
280.
Norman G. Eacott M. J. (2004 ). Impaired object recognition with increasing levels of feature ambiguity in rats with perirhinal cortex lesions. Behav. Brain Res. 148 79–91.
Not in our library10.1016/s0166-4328(03)00176-1 (opens in a new tab)
281.
Novkovic T. Mittmann T. Manahan-Vaughan D. (2015 ). BDNF contributes to the facilitation of hippocampal synaptic plasticity and learning enabled by environmental enrichment. Hippocampus 25 1–15.
Not in our library10.1002/hipo.22342 (opens in a new tab)
282.
O’Bryant S. E. Hobson V. Hall J. R. Waring S. C. Chan W. Massman P. (2009 ). Brain-derived neurotrophic factor levels in Alzheimer’s disease. J. Alzheimers Dis. 17 337–341.
Not in our library10.3233/jad-2009-1051 (opens in a new tab)
283.
O’Reilly K. Donohoe G. O’sullivan D. Coyle C. Corvin A. O’flynn P. (2019 ). A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder. BMC Psychiatry 19:27.
Not in our library10.1186/s12888-019-2018-6 (opens in a new tab)
284.
Old S. R. Naveh-Benjamin M. (2008 ). Differential effects of age on item and associative measures of memory: a meta-analysis. Psychol. Aging 23 104–118.
Not in our library10.1037/0882-7974.23.1.104 (opens in a new tab)
285.
Oler J. A. Markus E. J. (1998 ). Age-related deficits on the radial maze and in fear conditioning: hippocampal processing and consolidation. Hippocampus 8 402–415.
Not in our library10.1002/(sici)1098-1063(1998)8:4<402::aid-hipo8>3.0.co;2-i (opens in a new tab)
286.
Oliff H. S. Berchtold N. C. Isackson P. Cotman C. W. (1998 ). Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res. Mol. Brain Res. 61 147–153.
Not in our library10.1016/s0169-328x(98)00222-8 (opens in a new tab)
287.
Oral E. Canpolat S. Yildirim S. Gulec M. Aliyev E. Aydin N. (2012 ). Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res. Bull. 88 454–459.
Not in our library10.1016/j.brainresbull.2012.03.005 (opens in a new tab)
288.
Ozan E. Okur H. Eker C. Eker O. D. Gonul A. S. Akarsu N. (2010 ). The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res. Bull. 81 61–65.
Not in our library10.1016/j.brainresbull.2009.06.022 (opens in a new tab)
289.
Palomino A. Vallejo-Illarramendi A. Gonzalez-Pinto A. Aldama A. Gonzalez-Gomez C. Mosquera F. (2006 ). Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr. Res. 86 321–322.
Not in our library10.1016/j.schres.2006.05.028 (opens in a new tab)
290.
Pan W. Banks W. A. Fasold M. B. Bluth J. Kastin A. J. (1998 ). Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37 1553–1561.
Not in our library10.1016/s0028-3908(98)00141-5 (opens in a new tab)
291.
Pang P. T. Teng H. K. Zaitsev E. Woo N. T. Sakata K. Zhen S. (2004 ). Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306 487–491.
Not in our library10.1126/science.1100135 (opens in a new tab)
292.
Pardridge W. M. Wu D. Sakane T. (1998 ). Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pharm. Res. 15 576–582.
Not in our library10.1023/a:1011981927620 (opens in a new tab)
293.
Parihar M. S. Brewer G. J. (2010 ). Amyloid-beta as a modulator of synaptic plasticity. J. Alzheimers Dis. 22 741–763.
Not in our library10.3233/jad-2010-101020 (opens in a new tab)
294.
Patrylo P. R. Williamson A. (2007 ). The effects of aging on dentate circuitry and function. Prog. Brain Res. 163 679–696.
Not in our library10.1016/s0079-6123(07)63037-4 (opens in a new tab)
295.
Payton A. (2006 ). Investigating cognitive genetics and its implications for the treatment of cognitive deficit. Genes Brain Behav. 5(Suppl. 1), 44–53.
Not in our library10.1111/j.1601-183x.2006.00194.x (opens in a new tab)
296.
Pearson-Leary J. McNay E. C. (2012 ). Intrahippocampal administration of amyloid-beta(1-42) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism. J. Alzheimers Dis. 30 413–422.
Not in our library10.3233/jad-2012-112192 (opens in a new tab)
297.
Pencea V. Bingaman K. D. Wiegand S. J. Luskin M. B. (2001 ). Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J. Neurosci. 21 6706–6717.
Not in our library10.1523/jneurosci.21-17-06706.2001 (opens in a new tab)
298.
Peng S. Wuu J. Mufson E. J. Fahnestock M. (2005 ). Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease. J. Neurochem. 93 1412–1421.
Not in our library10.1111/j.1471-4159.2005.03135.x (opens in a new tab)
299.
Pezawas L. Verchinski B. A. Mattay V. S. Callicott J. H. Kolachana B. S. Straub R. E. (2004 ). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 24 10099–10102.
Not in our library10.1523/jneurosci.2680-04.2004 (opens in a new tab)
300.
Pietrelli A. Matkovic L. Vacotto M. Lopez-Costa J. J. Basso N. Brusco A. (2018 ). Aerobic exercise upregulates the BDNF-Serotonin systems and improves the cognitive function in rats. Neurobiol. Learn. Mem. 155 528–542.
Not in our library10.1016/j.nlm.2018.05.007 (opens in a new tab)
301.
Plancher G. Guyard A. Nicolas S. Piolino P. (2009 ). Mechanisms underlying the production of false memories for famous people’s names in aging and Alzheimer’s disease. Neuropsychologia 47 2527–2536.
Not in our library10.1016/j.neuropsychologia.2009.04.026 (opens in a new tab)
302.
A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays · 2015
No notice
303.
Pollock K. Dahlenburg H. Nelson H. Fink K. D. Cary W. Hendrix K. (2016 ). Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington’s disease mouse models. Mol. Ther. 24 965–977.
Not in our library10.1038/mt.2016.12 (opens in a new tab)
304.
Poon W. W. Blurton-Jones M. Tu C. H. Feinberg L. M. Chabrier M. A. Harris J. W. (2011 ). Beta-amyloid impairs axonal BDNF retrograde trafficking. Neurobiol. Aging 32 821–833.
Not in our library10.1016/j.neurobiolaging.2009.05.012 (opens in a new tab)
305.
Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons · 2011
No notice
306.
Radahmadi M. Hosseini N. Alaei H. Sharifi M. R. (2016 ). The effect of preventive, therapeutic and protective exercises on hippocampal memory mediators in stressed rats. Malays. J. Med. Sci. 23 29–37.
Not in our library10.21315/mjms2016.23.5.4 (opens in a new tab)
307.
Radak Z. Kaneko T. Tahara S. Nakamoto H. Pucsok J. Sasvari M. (2001 ). Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem. Int. 38 17–23.
Not in our library10.1016/s0197-0186(00)00063-2 (opens in a new tab)
308.
Radecki D. T. Brown L. M. Martinez J. Teyler T. J. (2005 ). BDNF protects against stress-induced impairments in spatial learning and memory and LTP. Hippocampus 15 246–253.
Not in our library10.1002/hipo.20048 (opens in a new tab)
309.
Rapp P. R. Gallagher M. (1996 ). Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc. Natl. Acad. Sci. U.S.A. 93 9926–9930.
Not in our library10.1073/pnas.93.18.9926 (opens in a new tab)
310.
Rasmussen P. Brassard P. Adser H. Pedersen M. V. Leick L. Hart E. (2009 ). Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp. Physiol. 94 1062–1069.
Not in our library10.1113/expphysiol.2009.048512 (opens in a new tab)
311.
Rasmussen T. Schliemann T. Sorensen J. C. Zimmer J. West M. J. (1996 ). Memory impaired aged rats: no loss of principal hippocampal and subicular neurons. Neurobiol. Aging 17 143–147.
Not in our library10.1016/0197-4580(95)02032-2 (opens in a new tab)
312.
Raz N. Lindenberger U. Rodrigue K. M. Kennedy K. M. Head D. Williamson A. (2005 ). Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb. Cortex 15 1676–1689.
Not in our library10.1093/cercor/bhi044 (opens in a new tab)
313.
Raz N. Lustig C. (2014 ). Genetic variants and cognitive aging: destiny or a nudge? Psychol. Aging 29 359–362.
Not in our library10.1037/a0036893 (opens in a new tab)
314.
Raz N. Rodrigue K. M. Kennedy K. M. Land S. (2009 ). Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology 23 105–116.
Not in our library10.1037/a0013487 (opens in a new tab)
315.
Dance training is superior to repetitive physical exercise in inducing brain plasticity in the elderly · 2018
No notice
316.
Reinhart V. Bove S. E. Volfson D. Lewis D. A. Kleiman R. J. Lanz T. A. (2015 ). Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder. Neurobiol. Dis. 77 220–227.
Not in our library10.1016/j.nbd.2015.03.011 (opens in a new tab)
317.
Rex C. S. Lauterborn J. C. Lin C. Y. Kramar E. A. Rogers G. A. Gall C. M. (2006 ). Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. J. Neurophysiol. 96 677–685.
Not in our library10.1152/jn.00336.2006 (opens in a new tab)
318.
Rex C. S. Lin C. Y. Kramar E. A. Chen L. Y. Gall C. M. Lynch G. (2007 ). Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus. J. Neurosci. 27 3017–3029.
Not in our library10.1523/jneurosci.4037-06.2007 (opens in a new tab)
319.
Ricarte J. J. Ros L. Latorre J. M. Watkins E. (2017 ). Mapping autobiographical memory in schizophrenia: clinical implications. Clin. Psychol. Rev. 51 96–108.
Not in our library10.1016/j.cpr.2016.11.004 (opens in a new tab)
320.
Riemenschneider M. Schwarz S. Wagenpfeil S. Diehl J. Muller U. Forstl H. (2002 ). A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer’s disease in patients lacking the apolipoprotein E epsilon4 allele. Mol. Psychiatry 7 782–785.
Not in our library10.1038/sj.mp.4001073 (opens in a new tab)
321.
Rios M. Fan G. Fekete C. Kelly J. Bates B. Kuehn R. (2001 ). Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15 1748–1757.
Not in our library10.1210/me.15.10.1748 (opens in a new tab)
322.
Roca M. Vives M. Lopez-Navarro E. Garcia-Campayo J. Gili M. (2015 ). Cognitive impairments and depression: a critical review. Actas Esp. Psiquiatr. 43 187–193.
Not in our library
323.
Rogers J. Renoir T. Hannan A. J. (2019 ). Gene-environment interactions informing therapeutic approaches to cognitive and affective disorders. Neuropharmacology 145 37–48.
Not in our library10.1016/j.neuropharm.2017.12.038 (opens in a new tab)
324.
Roig M. Nordbrandt S. Geertsen S. S. Nielsen J. B. (2013 ). The effects of cardiovascular exercise on human memory: a review with meta-analysis. Neurosci. Biobehav. Rev. 37 1645–1666.
Not in our library10.1016/j.neubiorev.2013.06.012 (opens in a new tab)
325.
Romero-Granados R. Fontan-Lozano A. Delgado-Garcia J. M. Carrion A. M. (2010 ). From learning to forgetting: behavioral, circuitry, and molecular properties define the different functional states of the recognition memory trace. Hippocampus 20 584–595.
Not in our library10.1002/hipo.20669 (opens in a new tab)
326.
Rosa E. Fahnestock M. (2015 ). CREB expression mediates amyloid beta-induced basal BDNF downregulation. Neurobiol. Aging 36 2406–2413.
Not in our library10.1016/j.neurobiolaging.2015.04.014 (opens in a new tab)
327.
Rosa E. Mahendram S. Ke Y. D. Ittner L. M. Ginsberg S. D. Fahnestock M. (2016 ). Tau downregulates BDNF expression in animal and cellular models of Alzheimer’s disease. Neurobiol. Aging 48 135–142.
Not in our library10.1016/j.neurobiolaging.2016.08.020 (opens in a new tab)
328.
Rosenzweig E. S. Barnes C. A. (2003 ). Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog. Neurobiol. 69 143–179.
Not in our library10.1016/s0301-0082(02)00126-0 (opens in a new tab)
329.
Russo-Neustadt A. A. Alejandre H. Garcia C. Ivy A. S. Chen M. J. (2004 ). Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29 2189–2199.
Not in our library10.1038/sj.npp.1300514 (opens in a new tab)
330.
Sambataro F. Murty V. P. Lemaitre H. S. Reed J. D. Das S. Goldberg T. E. (2010 ). BDNF modulates normal human hippocampal ageing [corrected]. Mol. Psychiatry 15 116–118.
Not in our library10.1038/mp.2009.64 (opens in a new tab)
331.
Sartorius A. Hellweg R. Litzke J. Vogt M. Dormann C. Vollmayr B. (2009 ). Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42 270–276.
Not in our library10.1055/s-0029-1224162 (opens in a new tab)
332.
Savaskan E. Muller-Spahn F. Olivieri G. Bruttel S. Otten U. Rosenberg C. (2000 ). Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer’s disease. Eur. Neurol. 44 172–180.
Not in our library10.1159/000008229 (opens in a new tab)
333.
Schaaf M. J. Workel J. O. Lesscher H. M. Vreugdenhil E. Oitzl M. S. De Kloet E. R. (2001 ). Correlation between hippocampal BDNF mRNA expression and memory performance in senescent rats. Brain Res. 915 227–233.
Not in our library10.1016/s0006-8993(01)02855-4 (opens in a new tab)
334.
Scharfman H. E. Maclusky N. J. (2005 ). Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? Trends Neurosci. 28 79–85.
Not in our library10.1016/j.tins.2004.12.005 (opens in a new tab)
335.
Selkoe D. J. (2001 ). Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81 741–766.
Not in our library10.1152/physrev.2001.81.2.741 (opens in a new tab)
336.
Seoane A. Tinsley C. J. Brown M. W. (2011 ). Interfering with perirhinal brain-derived neurotrophic factor expression impairs recognition memory in rats. Hippocampus 21 121–126.
Not in our library10.1002/hipo.20763 (opens in a new tab)
337.
Seong H. H. Park J. M. Kim Y. J. (2018 ). Antidepressive effects of environmental enrichment in chronic stress-induced depression in rats. Biol. Res. Nurs. 20 40–48.
Not in our library10.1177/1099800417730400 (opens in a new tab)
338.
Shafia S. Vafaei A. A. Samaei S. A. Bandegi A. R. Rafiei A. Valadan R. (2017 ). Effects of moderate treadmill exercise and fluoxetine on behavioural and cognitive deficits, hypothalamic-pituitary-adrenal axis dysfunction and alternations in hippocampal BDNF and mRNA expression of apoptosis - related proteins in a rat model of post-traumatic stress disorder. Neurobiol. Learn. Mem. 139 165–178.
Not in our library10.1016/j.nlm.2017.01.009 (opens in a new tab)
339.
Shaltiel G. Chen G. Manji H. K. (2007 ). Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr. Opin. Pharmacol. 7 22–26.
Not in our library10.1016/j.coph.2006.07.005 (opens in a new tab)
340.
Shetty A. K. Rao M. S. Hattiangady B. Zaman V. Shetty G. A. (2004 ). Hippocampal neurotrophin levels after injury: relationship to the age of the hippocampus at the time of injury. J. Neurosci. Res. 78 520–532.
Not in our library10.1002/jnr.20302 (opens in a new tab)
341.
Shilpa B. M. Bhagya V. Harish G. Srinivas Bharath M. M. Shankaranarayana Rao B. S. (2017 ). Environmental enrichment ameliorates chronic immobilisation stress-induced spatial learning deficits and restores the expression of BDNF, VEGF, GFAP and glucocorticoid receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 76 88–100.
Not in our library10.1016/j.pnpbp.2017.02.025 (opens in a new tab)
342.
A Large, Cross-Sectional Observational Study of Serum BDNF, Cognitive Function, and Mild Cognitive Impairment in the Elderly · 2014
No notice
343.
Shin M. K. Kim H. G. Baek S. H. Jung W. R. Park D. I. Park J. S. (2014 ). Neuropep-1 ameliorates learning and memory deficits in an Alzheimer’s disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques. Neurobiol. Aging 35 990–1001.
Not in our library10.1016/j.neurobiolaging.2013.10.091 (opens in a new tab)
344.
Shors T. J. Seib T. B. Levine S. Thompson R. F. (1989 ). Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science 244 224–226.
Not in our library10.1126/science.2704997 (opens in a new tab)
345.
Silhol M. Arancibia S. Maurice T. Tapia-Arancibia L. (2007 ). Spatial memory training modifies the expression of brain-derived neurotrophic factor tyrosine kinase receptors in young and aged rats. Neuroscience 146 962–973.
Not in our library10.1016/j.neuroscience.2007.02.013 (opens in a new tab)
346.
Silhol M. Bonnichon V. Rage F. Tapia-Arancibia L. (2005 ). Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats. Neuroscience 132 613–624.
Not in our library10.1016/j.neuroscience.2005.01.008 (opens in a new tab)
347.
Silva-Vargas V. Crouch E. E. Doetsch F. (2013 ). Adult neural stem cells and their niche: a dynamic duo during homeostasis, regeneration, and aging. Curr. Opin. Neurobiol. 23 935–942.
Not in our library10.1016/j.conb.2013.09.004 (opens in a new tab)
348.
Singh M. Meyer E. M. Simpkins J. W. (1995 ). The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136 2320–2324.
Not in our library10.1210/en.136.5.2320 (opens in a new tab)
349.
Siuciak J. A. Lewis D. R. Wiegand S. J. Lindsay R. M. (1997 ). Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56 131–137.
Not in our library10.1016/s0091-3057(96)00169-4 (opens in a new tab)
350.
Smith L. K. White C. W. III Villeda S. A. (2018 ). The systemic environment: at the interface of aging and adult neurogenesis. Cell Tissue Res. 371 105–113.
Not in our library10.1007/s00441-017-2715-8 (opens in a new tab)
351.
Smith M. A. Makino S. Kvetnansky R. Post R. M. (1995 ). Effects of stress on neurotrophic factor expression in the rat brain. Ann. N. Y. Acad. Sci. 771 234–239.
Not in our library10.1111/j.1749-6632.1995.tb44684.x (opens in a new tab)
352.
Smith P. J. Blumenthal J. A. Hoffman B. M. Cooper H. Strauman T. A. Welsh-Bohmer K. (2010 ). Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom. Med. 72 239–252.
Not in our library10.1097/psy.0b013e3181d14633 (opens in a new tab)
353.
Smith T. D. Adams M. M. Gallagher M. Morrison J. H. Rapp P. R. (2000 ). Circuit-specific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. J. Neurosci. 20 6587–6593.
Not in our library10.1523/jneurosci.20-17-06587.2000 (opens in a new tab)
354.
Snigdha S. De Rivera C. Milgram N. W. Cotman C. W. (2014 ). Exercise enhances memory consolidation in the aging brain. Front. Aging Neurosci. 6:3
Not in our library10.3389/fnagi.2014.00003 (opens in a new tab)
355.
Snyder E. M. Nong Y. Almeida C. G. Paul S. Moran T. Choi E. Y. (2005 ). Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8 1051–1058.
Not in our library10.1038/nn1503 (opens in a new tab)
356.
Sohrabji F. Bake S. (2006 ). Age-related changes in neuroprotection: is estrogen pro-inflammatory for the reproductive senescent brain? Endocrine 29 191–197.
Not in our library10.1385/endo:29:2:191 (opens in a new tab)
357.
Sole B. Bonnin C. M. Jimenez E. Torrent C. Torres I. Varo C. (2018 ). Heterogeneity of functional outcomes in patients with bipolar disorder: a cluster-analytic approach. Acta Psychiatr. Scand. 137 516–527.
Not in our library10.1111/acps.12871 (opens in a new tab)
358.
Sousa N. Lukoyanov N. V. Madeira M. D. Almeida O. F. Paula-Barbosa M. M. (2000 ). Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 97 253–266.
Not in our library10.1016/s0306-4522(00)00050-6 (opens in a new tab)
359.
Stern Y. (2006 ). Cognitive reserve and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 20 112–117.
Not in our library10.1097/01.wad.0000213815.20177.19 (opens in a new tab)
360.
Stranahan A. M. Zhou Y. Martin B. Maudsley S. (2009 ). Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents. Curr. Med. Chem. 16 4668–4678.
Not in our library10.2174/092986709789878292 (opens in a new tab)
361.
Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-d-aspartate receptor subunit 1 · 1997
Not checked
362.
Suire C. N. Eitan E. Shaffer N. C. Tian Q. Studenski S. Mattson M. P. (2017 ). Walking speed decline in older adults is associated with elevated pro-BDNF in plasma extracellular vesicles. Exp. Gerontol. 98 209–216.
Not in our library10.1016/j.exger.2017.08.024 (opens in a new tab)
363.
Szeszko P. R. Lipsky R. Mentschel C. Robinson D. Gunduz-Bruce H. Sevy S. (2005 ). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 10 631–636.
Not in our library10.1038/sj.mp.4001656 (opens in a new tab)
364.
Szuhany K. L. Bugatti M. Otto M. W. (2015 ). A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J. Psychiatr. Res. 60 56–64.
Not in our library10.1016/j.jpsychires.2014.10.003 (opens in a new tab)
365.
Takahashi M. Shirakawa O. Toyooka K. Kitamura N. Hashimoto T. Maeda K. (2000 ). Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 5 293–300.
Not in our library10.1038/sj.mp.4000718 (opens in a new tab)
366.
Tamatani M. Ogawa S. Nunez G. Tohyama M. (1998 ). Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death Differ. 5 911–919.
Not in our library10.1038/sj.cdd.4400439 (opens in a new tab)
367.
Tanila H. Shapiro M. L. Eichenbaum H. (1997 ). Discordance of spatial representation in ensembles of hippocampal place cells. Hippocampus 7 613–623.
Not in our library10.1002/(sici)1098-1063(1997)7:6<613::aid-hipo4>3.3.co;2-# (opens in a new tab)
368.
Tapia-Arancibia L. Aliaga E. Silhol M. Arancibia S. (2008 ). New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res. Rev. 59 201–220.
Not in our library10.1016/j.brainresrev.2008.07.007 (opens in a new tab)
369.
Teissier A. Soiza-Reilly M. Gaspar P. (2017 ). Refining the role of 5-HT in postnatal development of brain circuits. Front. Cell Neurosci. 11:139.
Not in our library10.3389/fncel.2017.00139 (opens in a new tab)
370.
Terry R. D. Masliah E. Salmon D. P. Butters N. Deteresa R. Hill R. (1991 ). Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 572–580.
Not in our library10.1002/ana.410300410 (opens in a new tab)
371.
Thoenen H. Sendtner M. (2002 ). Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 5(Suppl.), 1046–1050.
Not in our library10.1038/nn938 (opens in a new tab)
372.
Timmusk T. Palm K. Metsis M. Reintam T. Paalme V. Saarma M. (1993 ). Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10 475–489.
Not in our library10.1016/0896-6273(93)90335-o (opens in a new tab)
373.
Tsai S. F. Ku N. W. Wang T. F. Yang Y. H. Shih Y. H. Wu S. Y. (2018 ). Long-term moderate exercise rescues age-related decline in hippocampal neuronal complexity and memory. Gerontology 64 551–561.
Not in our library10.1159/000488589 (opens in a new tab)
374.
Tsai S. J. Gau Y. T. Liu M. E. Hsieh C. H. Liou Y. J. Hong C. J. (2008 ). Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia. Neurosci. Lett. 433 158–162.
Not in our library10.1016/j.neulet.2007.12.057 (opens in a new tab)
375.
Tsankova N. M. Berton O. Renthal W. Kumar A. Neve R. L. Nestler E. J. (2006 ). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9 519–525.
Not in our library10.1038/nn1659 (opens in a new tab)
376.
Tyler W. J. Perrett S. P. Pozzo-Miller L. D. (2002 ). The role of neurotrophins in neurotransmitter release. Neuroscientist 8 524–531.
Not in our library10.1177/1073858402238511 (opens in a new tab)
377.
van der Bij A. K. Laurant M. G. Wensing M. (2002 ). Effectiveness of physical activity interventions for older adults: a review. Am. J. Prev. Med. 22 120–133.
Not in our library10.1016/s0749-3797(01)00413-5 (opens in a new tab)
378.
van Praag H. Christie B. R. Sejnowski T. J. Gage F. H. (1999a ). Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl. Acad. Sci. U.S.A. 96 13427–13431.
Not in our library10.1073/pnas.96.23.13427 (opens in a new tab)
379.
van Praag H. Kempermann G. Gage F. H. (1999b ). Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 2 266–270.
Not in our library10.1038/6368 (opens in a new tab)
380.
van Praag H. Kempermann G. Gage F. H. (2000 ). Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 1 191–198.
Not in our library10.1038/35044558 (opens in a new tab)
381.
van Praag H. Shubert T. Zhao C. Gage F. H. (2005 ). Exercise enhances learning and hippocampal neurogenesis in aged mice. J. Neurosci. 25 8680–8685.
Not in our library10.1523/jneurosci.1731-05.2005 (opens in a new tab)
382.
Vasquez C. E. Riener R. Reynolds E. Britton G. B. (2014 ). NMDA receptor dysregulation in chronic state: a possible mechanism underlying depression with BDNF downregulation. Neurochem. Int. 79 88–97.
Not in our library10.1016/j.neuint.2014.09.007 (opens in a new tab)
383.
Vaynman S. Ying Z. Gomez-Pinilla F. (2004a ). Exercise induces BDNF and synapsin I to specific hippocampal subfields. J. Neurosci. Res. 76 356–362.
Not in our library10.1002/jnr.20077 (opens in a new tab)
384.
Vaynman S. Ying Z. Gomez-Pinilla F. (2004b ). Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur. J. Neurosci. 20 2580–2590.
Not in our library10.1111/j.1460-9568.2004.03720.x (opens in a new tab)
385.
Vedhara K. Hyde J. Gilchrist I. D. Tytherleigh M. Plummer S. (2000 ). Acute stress, memory, attention and cortisol. Psychoneuroendocrinology 25 535–549.
Not in our library10.1016/s0306-4530(00)00008-1 (opens in a new tab)
386.
Ventriglia M. Bocchio Chiavetto L. Benussi L. Binetti G. Zanetti O. Riva M. A. (2002 ). Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Mol. Psychiatry 7 136–137.
Not in our library10.1038/sj.mp.4000952 (opens in a new tab)
387.
Verburgh K. (2015 ). Nutrigerontology: why we need a new scientific discipline to develop diets and guidelines to reduce the risk of aging-related diseases. Aging Cell 14 17–24.
Not in our library10.1111/acel.12284 (opens in a new tab)
388.
Verhaeghen P. Marcoen A. Goossens L. (1993 ). Facts and fiction about memory aging: a quantitative integration of research findings. J. Gerontol. 48 157–171.
Not in our library10.1093/geronj/48.4.p157 (opens in a new tab)
389.
Vivar C. Potter M. C. Van Praag H. (2013 ). All about running: synaptic plasticity, growth factors and adult hippocampal neurogenesis. Curr. Top. Behav. Neurosci. 15 189–210.
Not in our library10.1007/7854_2012_220 (opens in a new tab)
390.
Voineskos A. N. Lerch J. P. Felsky D. Shaikh S. Rajji T. K. Miranda D. (2011 ). The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch. Gen. Psychiatry 68 198–206.
Not in our library10.1001/archgenpsychiatry.2010.194 (opens in a new tab)
391.
Volosin M. Song W. Almeida R. D. Kaplan D. R. Hempstead B. L. Friedman W. J. (2006 ). Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J. Neurosci. 26 7756–7766.
Not in our library10.1523/jneurosci.1560-06.2006 (opens in a new tab)
392.
Involvement Of BDNF In Age-Dependent Alterations In The Hippocampus · 2010
Not checked
393.
Voss M. W. Heo S. Prakash R. S. Erickson K. I. Alves H. Chaddock L. (2013 ). The influence of aerobic fitness on cerebral white matter integrity and cognitive function in older adults: results of a one-year exercise intervention. Hum. Brain Mapp. 34 2972–2985.
Not in our library10.1002/hbm.22119 (opens in a new tab)
394.
Walsh D. M. Selkoe D. J. (2004 ). Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron 44 181–193.
Not in our library10.1016/j.neuron.2004.09.010 (opens in a new tab)
395.
Wang D. C. Chen S. S. Lee Y. C. Chen T. J. (2006 ). Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons. Neurosci. Lett. 398 78–82.
Not in our library10.1016/j.neulet.2005.12.057 (opens in a new tab)
396.
Wardle R. A. Poo M. M. (2003 ). Brain-derived neurotrophic factor modulation of GABAergic synapses by postsynaptic regulation of chloride transport. J. Neurosci. 23 8722–8732.
Not in our library10.1523/jneurosci.23-25-08722.2003 (opens in a new tab)
397.
Weickert C. S. Hyde T. M. Lipska B. K. Herman M. M. Weinberger D. R. Kleinman J. E. (2003 ). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 8 592–610.
Not in our library10.1038/sj.mp.4001308 (opens in a new tab)
398.
Weinstein G. Beiser A. S. Choi S. H. Preis S. R. Chen T. C. Vorgas D. (2014 ). Serum brain-derived neurotrophic factor and the risk for dementia: the framingham heart study. JAMA Neurol. 71 55–61.
Not in our library10.1001/jamaneurol.2013.4781 (opens in a new tab)
399.
West M. J. (1993 ). Regionally specific loss of neurons in the aging human hippocampus. Neurobiol. Aging 14 287–293.
Not in our library10.1016/0197-4580(93)90113-p (opens in a new tab)
400.
Wilson I. A. Ikonen S. Gallagher M. Eichenbaum H. Tanila H. (2005 ). Age-associated alterations of hippocampal place cells are subregion specific. J. Neurosci. 25 6877–6886.
Not in our library10.1523/jneurosci.1744-05.2005 (opens in a new tab)
401.
Wilson R. S. Krueger K. R. Arnold S. E. Schneider J. A. Kelly J. F. Barnes L. L. (2007a ). Loneliness and risk of Alzheimer disease. Arch. Gen. Psychiatry 64 234–240.
Not in our library10.1001/archpsyc.64.2.234 (opens in a new tab)
402.
Wilson R. S. Scherr P. A. Schneider J. A. Tang Y. Bennett D. A. (2007b ). Relation of cognitive activity to risk of developing Alzheimer disease. Neurology 69 1911–1920.
Not in our library10.1212/01.wnl.0000271087.67782.cb (opens in a new tab)
403.
Wilson R. S. Schneider J. A. Boyle P. A. Arnold S. E. Tang Y. Bennett D. A. (2007c ). Chronic distress and incidence of mild cognitive impairment. Neurology 68 2085–2092.
Not in our library10.1212/01.wnl.0000264930.97061.82 (opens in a new tab)
404.
Wisdom N. M. Callahan J. L. Hawkins K. A. (2011 ). The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol. Aging 32 63–74.
Not in our library10.1016/j.neurobiolaging.2009.02.003 (opens in a new tab)
405.
Wolf S. A. Kronenberg G. Lehmann K. Blankenship A. Overall R. Staufenbiel M. (2006 ). Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer’s disease. Biol. Psychiatry 60 1314–1323.
Not in our library10.1016/j.biopsych.2006.04.004 (opens in a new tab)
406.
Woo N. H. Teng H. K. Siao C. J. Chiaruttini C. Pang P. T. Milner T. A. (2005 ). Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 8 1069–1077.
Not in our library10.1038/nn1510 (opens in a new tab)
407.
Wu A. Ying Z. Gomez-Pinilla F. (2004 ). The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur. J. Neurosci. 19 1699–1707.
Not in our library10.1111/j.1460-9568.2004.03246.x (opens in a new tab)
408.
Xu Y. Ku B. Tie L. Yao H. Jiang W. Ma X. (2006 ). Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res. 1122 56–64.
Not in our library10.1016/j.brainres.2006.09.009 (opens in a new tab)
409.
Yang K. Perez-Polo J. R. Mu X. S. Yan H. Q. Xue J. J. Iwamoto Y. (1996 ). Increased expression of brain-derived neurotrophic factor but not neurotrophin-3 mRNA in rat brain after cortical impact injury. J. Neurosci. Res. 44 157–164.
Not in our library10.1002/(sici)1097-4547(19960415)44:2<157::aid-jnr8>3.0.co;2-c (opens in a new tab)
410.
Yogeetha B. S. Haupt L. M. Mckenzie K. Sutherland H. G. Okolicsyani R. K. Lea R. A. (2013 ). BDNF and TNF-alpha polymorphisms in memory. Mol. Biol. Rep. 40 5483–5490.
Not in our library10.1007/s11033-013-2648-6 (opens in a new tab)
411.
Yu H. Zhang Z. J. Shi Y. M. Bai F. Qian Y. Yuan Y. G. (2008 ). [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 33 321–325.
Not in our library
412.
Zagrebelsky M. Holz A. Dechant G. Barde Y. A. Bonhoeffer T. Korte M. (2005 ). The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J. Neurosci. 25 9989–9999.
Not in our library10.1523/jneurosci.2492-05.2005 (opens in a new tab)
413.
Zeng Y. Liu Y. Wu M. Liu J. Hu Q. (2012 ). Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging. J. Alzheimers Dis. 31 765–778.
Not in our library10.3233/jad-2012-120886 (opens in a new tab)
414.
Zeng Y. Tan M. Kohyama J. Sneddon M. Watson J. B. Sun Y. E. (2011 ). Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging. J. Neurosci. 31 17800–17810.
Not in our library10.1523/jneurosci.3878-11.2011 (opens in a new tab)
415.
Zhang J. Yu Z. Yu Z. Yang Z. Zhao H. Liu L. (2011 ). rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model. Int. J. Clin. Exp. Pathol. 4 496–504.
Not in our library
416.
Zhang N. Xing M. Wang Y. Tao H. Cheng Y. (2015 ). Repetitive transcranial magnetic stimulation enhances spatial learning and synaptic plasticity via the VEGF and BDNF-NMDAR pathways in a rat model of vascular dementia. Neuroscience 311 284–291.
Not in our library10.1016/j.neuroscience.2015.10.038 (opens in a new tab)
417.
Zhang Q. Wang X. Bai X. Xie Y. Zhang T. Bo S. (2017 ). Resveratrol reversed chronic restraint stress-induced impaired cognitive function in rats. Mol. Med. Rep. 16 2095–2100.
Not in our library10.3892/mmr.2017.6851 (opens in a new tab)
418.
Zhang X. Y. Chen D. C. Xiu M. H. Haile C. N. Luo X. Xu K. (2012 ). Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum. Genet. 131 1187–1195.
Not in our library10.1007/s00439-012-1150-x (opens in a new tab)
419.
Zhang Y. Fang X. Fan W. Tang W. Cai J. Song L. (2018 ). Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study. Psychopharmacology 235 1191–1198.
Not in our library10.1007/s00213-018-4835-6 (opens in a new tab)
420.
Zheng Z. Sabirzhanov B. Keifer J. (2010 ). Oligomeric amyloid-{beta} inhibits the proteolytic conversion of brain-derived neurotrophic factor (BDNF), AMPA receptor trafficking, and classical conditioning. J. Biol. Chem. 285 34708–34717.
Not in our library10.1074/jbc.m110.150821 (opens in a new tab)
421.
Zhou D. Zhang Z. Liu L. Li C. Li M. Yu H. (2017 ). The antidepressant-like effects of biperiden may involve BDNF/TrkB signaling-mediated BICC1 expression in the hippocampus and prefrontal cortex of mice. Pharmacol. Biochem. Behav. 157 47–57.
Not in our library10.1016/j.pbb.2017.02.004 (opens in a new tab)
422.
Zhou F. C. Wang Y. Y. Zheng W. Ungvari G. S. Ng C. H. Yuan Z. (2018 ). Prospective memory in bipolar disorder: a meta-analysis. Psychiatry Res. 259 184–190.
Not in our library10.1016/j.psychres.2017.09.073 (opens in a new tab)
423.
Zimbone S. Monaco I. Giani F. Pandini G. Copani A. G. Giuffrida M. L. (2018 ). Amyloid beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells. Aging Cell 17:e12684.
Not in our library10.1111/acel.12684 (opens in a new tab)
424.
Zuccato C. Marullo M. Conforti P. Macdonald M. E. Tartari M. Cattaneo E. (2008 ). Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington’s disease. Brain Pathol. 18 225–238.
Not in our library10.1111/j.1750-3639.2007.00111.x (opens in a new tab)
425.
Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder · 2018
No notice

Cited by papers we hold 14

Impact of probiotic supplementation on serum levels of brain-derived neurotrophic factor: GRADE-based dose-response meta-analysis · 2025
Not checked
Tumor microenvironment in glioblastoma: Current and emerging concepts · 2023
No notice
Bi-directional elucidation of Lactiplantibacillus plantarum (RTA 8) intervention on the pathophysiology of gut-brain axis during Salmonella brain infection · 2022
Not checked
Multi-omics studies reveal ameliorating effects of physical exercise on neurodegenerative diseases · 2022
Not checked
The role of lipocalin 2 in brain injury and recovery after ischemic and hemorrhagic stroke · 2022
Not checked
Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder · 2022
Not checked
Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art · 2022
Not checked
A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy · 2022
Not checked
Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis · 2022
Not checked
A preview of selected articles · 2021
Not checked
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming · 2021
No notice
Effects of physical activities on dementia‐related biomarkers: A systematic review of randomized controlled trials · 2020
Not checked
Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer · 2020
No notice
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease · 2020
No notice

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.